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Abstract
Viral hemorrhagic septicemia virus (VHSV) is one of the most devastating and
problematic viral fish diseases to plague the European aquaculture industry, and due to its
pathogenicity, disease course, mortality rates, and wide host range, remains one of the
most pathogenic viral diseases of finfish worldwide. A new freshwater strain of viral
hemorrhagic septicemia virus IVb (VHSV-IVb) in the Great Lakes has been found
capable of infecting a wide number of naive species, and has been associated with large
fish kills in the Midwestern United States since its discovery in 2005. In this study, the
yellow perch, Perca flavescence, one such species documented in several fish kills
affiliated with VHSV, was used as a research model to elucidate host-virus interactions to
better understand the mechanisms of viral infection. A direct comparison of viral
infection kinetics and net mortality among yellow perch stocks derived from distinct
genetic and geographic regions found large variation in susceptibility to the disease,
suggesting that genetic variance within a population can play a significant role in survival
after infection with VHSV-IVb. Upon investigation of the early acute innate immune
ii

response after exposure to the VHS virus, a significant up-regulation of Mx expression in
the liver, as well as the inflammatory response genes IL-1β and SAA, in all three tissues
sampled, head kidney, spleen, and liver, was directly correlated to viral load indicating
the role of these genes in the initial stages of infection. Viral load increased most rapidly
in the head kidney and spleen, suggesting that potential down-regulation of Mx in these
tissues may represent a viral strategy to increase replication. Finally, when the pathology
and distribution of the virus were monitored in different tissues of adult fish exhibiting a
low level of VHSV infection over time, the finding of significant viral load in the gills
and blood suggest that the sampling of these tissues may offer a more accurate, non-lethal
alternative to viral screening from the currently, more traditional and lethal cell culture
analysis of the head kidney/spleen. A significant viral load in the brain, however,
particularly in the later stages of infection, also suggests that latent virus may remain in
the brain neurons undetected in asymptomatic carriers of the virus, classifying the VHS
virus as neurotropic, as well as a hemorrhagic.
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Chapter 1 - Introduction & Objectives

Due to its broad host range and acute nature, viral haemorrhagic septicaemia (VHS)
is one of the most problematic viral fish diseases to plague the aquaculture industry, and
remains one of the most pathogenic viral diseases of finfish worldwide (Kim & Faisal,
2011; Wolf, 1988). In areas of Europe, VHS infections in farmed rainbow trout
(Oncorhynchus mykiss) have resulted in extremely high mortalities, causing extensive
economic losses (Einer-Jensen et al., 2004; Olesen, 1998; Skall et al., 2005; Smail, 1999;
Wolf, 1988) and, thus, is currently listed as a reportable disease by the World
Organization for Animal Health (OIE, 2012). Viral haemorrhagic septicaemia virus
(VHSV) isolates of marine origin have been identified in North America, Europe, and
Asia where they cause disease in both farmed and wild species (Kim et al., 2003; King et
al., 2001; Meyers & Winton, 1995; Mortensen et al., 1999; Nishizawa et al., 2002). In
2005, a new freshwater strain of VHSV was isolated from tissue of an adult muskellunge,
(Esox masquinongy), collected in 2003 from Lake St. Clair, Michigan, part of the Great
Lakes of North America (Elsayed et al., 2006). This novel sublineage, named Great
Lakes VHSV-IVb, was subsequently associated with massive fish kills that included
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freshwater drum (Aplodinotus grunniens) (Lumsden et al., 2007), muskellunge, round
goby (Neogobius melanostomas) (Groocock et al., 2007), gizzard shad (Dorosoma
cepedianum), and yellow perch (Perca flavescens), in Lake St. Clair, Lake Erie, and Lake
Ontario (Figure 1-1.) (Kim & Faisal, 2011). When VHSV was confirmed for the first
time in the U.S. in the Great Lakes of North America in 2005, the United States
Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS)
immediately took action to prevent any further spread of the disease by issuing a Federal
Order prohibiting the transport of any VHS-susceptible fish species from any VHSaffected or at risk states without specific disease testing and inspection of the facility
(Figure 1-2). In an effort to slow the spread of the virus to inland lakes and rivers, the
Federal government ordered strict restrictions on the transfer of susceptible species from
the Great Lakes watershed into other regions of the U.S. (USDA, 2008). Because of the
severe pathogenicity of the disease and the ever-increasing number of host-environments
in which the virus is found, the study of VHS remains a top priority worldwide.

Figure 1-1. A VHSinduced fish kill
documented in the
Great Lakes of North
America shortly after
the discovery of a
new freshwater strain
of virus, VHSV-IVb
(U.S. Fish & Wildlife,
2008).
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September 9, 2008
Species regulated by title 9 CFR Parts 83.1 through 83.7, 93.900 and 93.910 through
93.916 (the Viral Hemorrhagic Septicemia (VHS) Interim Rule)
The United States Department of Agriculture (USDA), Animal and Plant Health
Inspection Service (APHIS), Veterinary Services (VS) has identified the following
species as having originated in freshwater locations in the United States and/or Canada,
and as having been infected by VHS virus under natural (i.e. non-experimental)
conditions of exposure; and from which VHS virus has been isolated by cell culture, with
confirmation of strain identity through molecular detection. Anadromous fish species
that have migrated into freshwater and from which VHS strain type IV(a) is isolated are
excluded from this definition.
For regulatory purposes, presence of the viral pathogen and clinical expression of disease
caused by the virus are considered synonymous.
Black crappie
Bluegill
Bluntnose minnow
Brown bullhead
Brown trout
Burbot
Channel catfish
Chinook salmon
Emerald shiner
Freshwater drum
Gizzard shad
Lake whitefish
Largemouth bass
Muskellunge
Shorthead redhorse
Northern Pike
Pumpkinseed
Rainbow trout
Rock bass
Round goby
Silver redhorse
Smallmouth bass
Spottail shiner
Trout-Perch
Walleye
White bass
White perch
Yellow perch

Pomoxis nigromaculatus
Lepomis macrochirus
Pimephales notatus
Amieurus nebulosus
Salmo trutta
Lota lota
Ictalurus punctatus
Oncorhynchus tshawytscha
Notropis atherinoides
Aplodinotus grunniens
Dorosoma cepedianum
Coregonus clupeaformis
Micropterus salmoides
Esox masquinongy
Moxostoma macrolepidotum
Esox lucius
Lepomis gibbosus
Oncorhynchus mykiss
Ambloplites rupestris
Neogobius melanostomus
Moxostoma anisurum
Micropterus dolomieu
Notropis hudsonius
Percopsis omiscomaycus
Sander vitreus
Morone chrysops
Morone americana
Perca flavescens

Figure 1-2. As of 2008, 28 new species of freshwater fish in the Great Lakes
demonstrated susceptibility to VHSV-IVb resulting in the transfer of live fish to
uninfected regions of the U.S. to become federally regulated (USDA, 2008).
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Genotypic analysis has classified VHSV as a negative-sense RNA virus. Its
bullet shaped structure and 11kb genome have classified it as part of the Rhadboviridae
family of the newly recognized Novirhabdovirus genus. While rhabdoviruses are among
the most widely distributed viruses in nature, infecting plants, invertebrates and
vertebrate hosts, the most well-known, and well-studied include the mammalian
rhabdoviruses, rabies and vesicular stomatitis virus (VSV). The 11kb VHSV genome
consists of six genes including,-the nucleoprotein (N), phosphoprotein (P), matrix protein
(M), glycoprotein (G), non-virion protein (NV), and the viral RNA polymerase (L)
(Figure 1-3A.) (Schutze et al., 1999). Like all negative-sense RNA viruses, once inside a
host-cell the viral RNA cannot be directly accessed by host ribosomes to form proteins.
Instead, the RNA must first be transcribed by its own viral RNA polymerase into a
"readable" complementary positive-sense mRNA transcript. Thus, intact, functional viral
polymerase (L) must be safely transported in the host cell by the virus in order for it to
replicate and become infectious (Figure 1-3).
The sixth gene, which encodes a non-virion protein (NV) is unique to fish
rhabdoviruses including VHSV and has resulted in their sub-classification into the
novirhabdovirus genus. While the function of the non-virion protein remains unknown, a
large variation in the NV genomic sequence and subsequent protein structure between
fish rhabdoviruses suggests that there is a relatively low level of evolutionary constraint
on the NV gene (Kurath et al., 1997).
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Figure 1-3. The Rhabdovirus virus life cycle. A simplified rhabdovirus life cycle can be
divided into four phases. (1) The virus binds to the cell and enters by phagocytosis, (2)
followed by fusion of the glycoprotein and matrix membrane to release the viral genome
and viral polymerase into the cell cytoplasm (uncoating), (3) resulting in transcription of a
positive-sense RNA that translated into viral proteins by the cellular endoplasmic
reticulum (ER) and Golgi apparatus. (4) The pos-sense RNA is replicated back into a negsense RNA and the life cycle completed by assembly of the viral components and release
of the virus through budding (Schnell et al., 2010).
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The clinical signs of an acute VHS manifestation of the disease are often nonspecific, appearing singly or in a combination of either dermal petichial hemorrhages,
hemorrhaging at the base of the fins (Figure 1-4 & 1-5A), muscles, internal organs
(Figure 1-5B), and exophthalmia (Figure 1-5C). Ascites is often observed upon necropsy.
In acute forms of the disease, mortality is rapid and commonly as high as 100% in
juvenile fish, and as much as 30-90% in adults. In chronic forms of the disease, however,
fish become infected with the virus without showing any outward clinical signs or
pathology of the disease (Batts & Winton, 2007; Skall et al., 2005). These fish experience
a prolonged course with lingering low levels of mortality, and possibly shed the virus into
the surrounding environment acting as covert carriers of the disease. In some hosts, a
chronic infection is characterized by nervous behavior and erratic swimming (Kim &
Faisal, 2010a; Wolf, 1988). Recent studies also demonstrate that the main portal of viral
entry and replication is at the base of the pelvic and pectoral fins (Harmache et al., 2006;
Montero et al., 2011).

Figure 1-4. Juvenile northern pike exhibiting characteristic external clinical signs of VHS
consisting primarily of severe hemorrhage throughout the body. Image by Dr. Mohamed Faisal
(MSU,Lansing MI)
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A.

B.

C.

Figure 1-5. Clinical manifestation of VHS most often consists of (A.) moderate to
severe petichial hemorrhage throughout the body, (B.) hemorrhage of the muscle and
internal organs, (C.) swelling behind the eye, or exophthalmia. Images credit of Dr. Jim
Winton (USGS, Seattle, WA), Dr. Mohamed Faisal (MSU, Lansing, MI), and Dr. Paul Bowser
(Cornell, Ithaca, NY)

History of VHSV
The first reported clinical signs of VHS infecting freshwater rainbow trout in Europe
date back to 1938. It was not until 1962, however, that the virus was isolated and viral
etiology confirmed. Until the late 1980s, the VHS virus was thought to exclusively target
rainbow trout farmed in Europe until, in 1988, through routine viral screening of
spawning salmonid broodstocks, a marine form of the VHSV was isolated for the first
time in the Pacific Northwest in Washington State in chinook salmon (Oncorhynchus
tshawytscha) and coho salmon (Oncorhynchus tshawytscha) (Winton et al., 1989). At the
time, VHSV had never been isolated outside of Europe, therefore, it was speculated that
the virus must have originated through imported Atlantic salmon eggs from Europe. In
1990, however, a pacific cod (Gadus macrocephalus) caught in Prince William Sound,
Alaska, exhibited lesions similar to those described in Europe. Upon examination by the
pathology staff of the Alaska Department of Fish and Game, the marine strain of the virus
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was again confirmed. This isolation provided the first evidence that a marine reservoir of
the virus existed and may have led to the infected salmonids isolated earlier in
Washington state (Amos et al., 1998). Following this discovery, isolations of VHSV
became widespread and problematic in hatcheries along the marine coastal regions of
North America, where it has been particularly associated with substantial mortality in
Pacific herring (Clupea harengus pallas), Pacific hake (Merluccius productus), and
walleye pollock (Theragra chalcomgramma) (Kocan et al., 1997; Meyers et al., 1999;
Meyers & Winton, 1995).
Since its discovery in the North Pacific, VHSV has been found in other marine fish
worldwide, including turbot (Scophthalmus maximus) farmed in the Baltic Sea, and olive
flounder (Paralichthys olivaceus) farmed in Japan (Isshik et al., 2001; King et al., 2001;
Mortensen et al., 1999; Nishizawa et al., 2002). As VHSV continued to be isolated from
an increasing number of marine species around the world, it soon became clear that the
virus was more geographically widespread and less species-specific than previously
thought. With further genetic analysis, it was concluded that the freshwater virus,
originally known to infect rainbow trout in Europe, was actually derived from the marine
form of the virus (Skall et al., 2005).
In an effort to prevent the spread of this voracious pathogen, the European Union
enforced strict restrictions on trade between zones where the pathogen was endemic, and
between zones which were considered VHSV-free. While an aggressive VHS virus
eradication program has successfully reduced the number of infected farms, the virus
continues to be problematic throughout fish farms in continental Europe. Several studies
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have recently indicated that VHS non-susceptible individuals may be acting as active
covert carriers of VHS, serving as the primary source of viral spread into fish farms. It is
suggested that these carrier fish act as viral reservoirs, continually shedding the virus at
low to non-detectable levels while showing no clinical pathology of the disease. In
addition, while the practice of pasteurizing fish feeds has significantly contributed to the
reduction of VHSV in fish culture facilities, the introduction of the virus can still occur
through the import of contaminated fish or fish eggs, or by waterborne virus in the water
supply (Kurath, 2012). Once the virus establishes itself in a population, this opportunistic
pathogen may remain hidden or latent in apparently healthy populations of fish until a
significant stressor, such as spawning, sustained harassment by predators, severe
temperature change, nutritional deprivation, or acute exposure to pollutants
(hydrocarbons) trigger an active infection and subsequently lethal outbreak of the disease
(Amos et al., 1998; King et al., 2001; Mortensen et al., 1999; Skall et al., 2005; Smail,
1999).

VHSV in the Great Lakes
The first isolate of VHSV was discovered in 2005 in the Great Lakes during a routine
survey to determine the spread of the intracellular bacterium, Piscirickettsia sp., in adult
muskellunge (Esox masquinongy) from Lake St. Clair, Michigan (Elsayed et al., 2006).
Upon more intense investigation, the same exact strain of VHSV was then isolated from
4 of 42 muskellunge that had been collected in 2003. Since no other form of the virus had
been previously reported in Great Lakes fish species prior to this discovery, a study was
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immediately initiated to sequence the virus in an effort to identify its possible source.
Nucleotide sequence analysis demonstrated that this was an entirely new strain of
freshwater VHSV, most closely related to the North American genotype IV of marine
VHSV and clearly distinct from the three known European genotypes (Figure 1-6.). This
implies that, the Great Lakes strain of freshwater VHS, now referred to as the North
American IVb virus, evolved from the North American marine coastal virus, now
referred to as IVa, through adaptation to its new freshwater hosts of the Great Lakes
(Ammayappan & Vakharia, 2009; Einer-Jensen et al., 2004; Elsayed et al., 2006).
Following this discovery, in 2005 VHSV was associated with a large fish kill
consisting of freshwater drum (Aplodinotus grunniens), muskellunge, round goby
(Neogobius melanostomas), striped bass (Morone saxatilis), three-spined stickleback
(Gasterosteus aculeatus), mud minnows (Fundulus heteroclitus), and brown trout (Salmo
trutta) in Lake Ontario, as well as muskellunge in Lake St. Clair. In 2006, another large
die-off of round goby and muskellunge in the St. Lawrence River, followed by significant
fish kills of muskellunge, northern pike (Esox lucius), gizzard shad (Dorosoma
cepedianum), smallmouth bass (Micropterus dolomieu), walleye (Sander vitreus), and
yellow perch (Perca flavescens) throughout Lake St. Clair, Lake Erie and Lake Ontario
(USDA, 2006), were all found to be associated with VHSV. In 2008, the U.S.
Department of Agriculture, Animal and Plant Health Inspection Service, listed 28
different fish species native to the Great Lakes as VHS-susceptible (Figure 1-2.);
however this list is expected to grow as more potentially susceptible species are
investigated. Since its discovery, VHS has been isolated in all five of the Laurentian
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Great Lakes of North America, Lake Winnebago, WI, and several smaller inland lakes
located in Michigan, Ohio, and New York (Figure 1-7.).

Figure 1-6. Phylogenetic relationship of the glycoprotein sequences across
48 different VHSV isolates. The Great Lakes strain M103GL (circled)
forms its own unique sublineage IVb, whereas all other North American
isolates collected thus far fall under sublineage IVa (from Ammayappan and
Vakharia, (2009)).
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Figure 1-7. VHSV-IVb has been confirmed in each of the Great Lakes as
well as several smaller lakes in the states of Michigan, Ohio, and New
York (USDA-APHIS, 2010).
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The VHSV-IVb strain is noteworthy to the field of virology, as well as the wild
fisheries and aquaculture industry, in that it represents a geographic invasion of an
extensive freshwater ecosystem and it is the first time the virus has been known to cause
large-scale epidemics in wild freshwater fish populations. Several distinct features set this
virus apart from its European counterparts and its marine ancestors, the most striking
being the broad new host range of freshwater fish species this virus has acquired in a very
short period of time. Genetic typing of the virus isolated from fish kills throughout the
Great Lakes currently indicate very low genetic diversity, implying that this is a very
early point in the emergence of the virus. In contrast, the much more familiar and diverse
European strain of freshwater VHSV continues to exclusively target only freshwater
salmonids. Gradual, species-specific adaptation to a host environment based on
successful replication and disbursement is the pathogenic behavior exhibited most
commonly by viruses. However, it is very unusual to witness the evolution of this process
over such a short period of time (Kurath, 2010). Therefore, studying the mechanisms of
how such a virus can infect its host successfully, will not only provide valuable insight
into the teleost immune system, but possibly offer insight regarding how viruses may
quickly evolve to infect multiple host species with tremendous diversity and speed.

The Yellow Perch as a Research Model
The discovery of a novel strain of viral hemorrhagic septicemia virus (VHSV) in the
Laurentian Great Lakes and the associated fish kills have raised much concern over the
ability of this virus to infect a large range of freshwater species with devastating
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consequences. The yellow perch (Perca flavescens) has been a large part of many of the
die-offs associated with VHSV in the Great Lakes, and thus, has been listed as a highly
susceptible species to the disease (Kane-Sutton et al., 2010). The natural distribution of
the yellow perch ranges throughout much of North America from the Northern provinces
of Canada, into the eastern and southern United States. In addition, human introductions
and dispersal has resulted in the yellow perch being introduced into several western
regions of the United States (Figure 1-8.) (Brown et al., 2009).

Figure 1-8. Native and introduced distribution of yellow perch
in North America from (Bradford et al., 2008). While the virus
has been contained primarily to the Great Lakes basin, the
virus susceptibility and wide range of the yellow perch,
however, may allow for the virus to spread undetected into new
regions.
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The yellow perch is also known for its extremely high commercial and aquaculture
value. Commercial fishing is predominantly successful in the Great Lakes, particularly in
Lake Erie and in Green Bay, WI (directly connected to Lake Michigan) (Brown et al.,
2009). Yellow perch harvests from the Great Lakes peaked at 14,900 metric tons/year in
the 1950s, but have continued to decline to 5,000 – 8,200 metric tons/year in the 1980s
and 1990s (Malison, 2003) due to predation, pollution, invasive organisms, and overfishing. A high consumer demand, combined with an increase on commercial fisheries
closures and restrictions, has thus fueled a recent increase in yellow perch aquaculture.
The challenges and risks associated with preventing potential VHS outbreaks in fisheries
and aquaculture systems outside of the Great Lakes have been high; however they can be
expected to rise to an even greater extent if the virus is successful at spreading across the
region. In addition, while the virus to date has seemingly been contained to the Great
Lakes region, the high susceptibility of the yellow perch to the Great Lakes virus,
combined with its wide range of habitats and distribution as a prey species, may allow
this fish species to potentially act as a covert carrier, facilitating the spread of VHS into
the inland rivers and lakes throughout North America. Thus, the yellow perch will serve
as an ideal research model to aid in understanding how freshwater fish are recognizing
this pathogen, as well as the mechanisms this virus can utilize to replicate and spread.
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Summary/Main Objectives
Using the yellow perch as a research model in a controlled laboratory setting, the basic
objectives outlined in this study will aid in the preliminary development of a disease
resistant stock, new methods of non-lethal sampling and enhanced viral detection, and
contribute towards a greater understanding of the mechanisms of viral infection as well as
the fish’s primary antiviral immune defenses. The first objective will compare differences
in resistance or susceptibility to the Great Lakes strain of VHS within three different
broodstock populations of fish with varying geographic and genetic origins. The second
objective focuses specifically on elucidating the early immune response necessary for an
effective defense against invading viral pathogens. Improving our understanding of the
innate mechanism used by the fish to combat invading pathogens will not only result in
improved aquaculture practices, potential vaccine development, and treatment strategies
leading to more sustainable healthy fish populations, but contribute towards our greater
understanding of the evolution of various immune system mechanisms and responses in
lower vertebrates. The final objective will examine how and where the virus replicates
and spreads within different tissues throughout the fish after exposure, ranging from the
fins, gills, blood, liver, kidney, spleen, brain, and blood, and how this distribution
changes over time. This knowledge will not only aid in our understanding of the viral
mechanisms of infection, but may challenge the current methodologies in viral detection
and surveillance as previously unknown potential reservoirs of the virus are explored.
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Main objectives are proposed in this study:
I. Assess the susceptibility of different yellow perch broodstocks of genetic
variability and geographic origin to the Great Lakes strain of VHS IVb to
evaluate the potential for a disease resistance stock. (Chapter 2)

II. Conduct an analysis of immunologically relevant tissue in yellow perch
infected with VHSV describing innate immune response pathways
characteristic to early, or pre-disease, stages of infection. (Chapter 3)

III. Determine how the relative distribution of virus within key internal organs
of infected fish develops and changes over the course of infection, as well as
identify potential organs where virus may be found in asymptomatic
carriers. (Chapter 4)
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Comparative susceptibility among three stocks of yellow perch (Perca flavescens)
to viral haemorrhagic septicaemia virus (VHSV) strain IVb from the Great Lakes
Olson, W1., Emmenegger, E2., Glenn, J2., Winton,J2., & Goetz, F.1,3
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University of WI-Milwaukee, 2U.S. Geological Survey (USGS), Seattle, WA, 3National
Oceanic and Atmospheric Administration (NOAA), Port Orchard, WA

"The Great Lakes strain of viral haemorrhagic septicaemia virus IVb (VHSV-IVb) is
capable of infecting a wide number of naive species and has been associated with large
fish kills in the Midwestern United States since its discovery in 2005. The yellow perch
(Perca flavescens),a freshwater species commonly found throughout inland waters of the
United States and prized for its high value in sport and commercial fisheries, is a species
documented in several fish kills affiliated with VHS. In the present study, differences in
survival after infection with VHSV-IVb were observed among juvenile fish from three
yellow perch broodstocks that were originally derived from distinct wild populations,
suggesting innate differences in susceptibility due to genetic variance. While all three
stocks were susceptible upon water-born exposure to VHS virus infection, fish derived
from the Midwest (Lake Winnebago, WI) showed significantly lower cumulative percent
survival compared with two perch stocks derived from the East Coast (Perquimans River,
NC and Choptank River, MD) of the United States. However, despite differences in
apparent susceptibility, clinical signs did not vary between stocks and included moderate
to severe haemorrhages at the pelvic and pectoral fin bases and exophthalmia. After the
28-day challenge was complete, VHS virus was analyzed in subsets of whole fish that had
either survived or succumbed to the infection using both plaque assay and quantitative
PCR methodologies. A direct correlation was identified between the two methods,
suggesting the potential for both methods to be used to detect virus in a research setting."
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Introduction
Due to its broad host range and acute nature, viral hemorrhagic septicemia (VHS) is
one of the most problematic viral fish diseases to plague the aquaculture industry, and
remains one of the most pathogenic viral diseases of finfish worldwide (Kim & Faisal,
2011; Wolf, 1988). In areas of Europe, VHS infections in farmed rainbow trout,
Oncorhynchus mykiss, have resulted in extremely high mortalities, causing extensive
economic losses (Einer-Jensen et al., 2004; Olesen, 1998; Skall et al., 2005; Smail, 1999;
Wolf, 1988). Viral hemorrhagic septicemia virus (VHSV) isolates of marine origin have
been identified in North America, Europe, and Asia where they cause disease in both
farmed and wild species (Kim et al., 2003; King et al., 2001; Meyers & Winton, 1995;
Mortensen et al., 1999; Nishizawa et al., 2002). In 2005, a new freshwater strain of
VHSV was isolated from tissue of an adult muskellunge (Esox masquinongy), collected
in 2003 from Lake St. Clair, Michigan, part of the Great Lakes of North America
(Elsayed et al., 2006). This novel sublineage, named Great Lakes VHSV-IVb, was
subsequently associated with large fish kills that included freshwater drum (Aplodinotus
grunniens) (Lumsden et al., 2007), muskellunge, round goby (Neogobius melanostomas)
(Groocock et al., 2007), gizzard shad (Dorosoma cepedianum), and yellow perch (Perca
flavescens), in Lake St. Clair, Lake Erie, and Lake Ontario (Kim & Faisal, 2011). To
date, the Great Lakes strain of VHSV-IVb has been isolated from at least 31 species of
fish in the Great Lakes, several smaller inland lakes and the upper portion of the St.
Lawrence River (Thompson et al., 2011a). Because of the severe pathogenicity of the
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disease and the ever-increasing number of host-environments in which the virus is found,
the study of VHS remains a top priority worldwide.
The yellow perch is well known throughout North America for its high value to
aquaculture, commercial and sport fisheries. This species has also been included in
several of the fish kills that have occurred throughout the region in association with the
Great Lakes VHS-IVb virus, and was the primary species affected in a large die-off in
central Lake Erie (Kane-Sutton et al., 2010). While yellow perch susceptibility to Great
Lakes VHSV-IVb has been tested relative to other fish species (Kim & Faisal, 2010b),
variations in susceptibility within different perch populations have not been addressed.
Because yellow perch primarily live in lake ecosystems, gene flow between these inland
ecosystems is limited and, thus, there are great genetic differences between populations.
Therefore, populations of yellow perch that originate from different genetic backgrounds
and geographic regions may have developed fundamental differences in their
susceptibility or resistance to the virus.
In the present study, three yellow perch broodstocks derived from wild populations
having different geographic origins and genetic backgrounds (Grzybowski et al., 2010;
Todd & Hatcher, 1993), were challenged with VHSV-IVb to evaluate (measured by %
survival) the VHS resistance of each stock. Offspring from the three stocks were
propagated under identical conditions with environmental factors such as diet, water
temperature, flow rates, and fish densities kept the same between fish stocks. Thus, with
all other variables held equal, the genetic origins of the fish would be the principle
component involved in disease susceptibility or resistance.
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Materials and Methods
Yellow perch stocks
The yellow perch populations used in the present study are part of a broodstock
development program for aquaculture (Rosauer et al., 2011) at the University of
Wisconsin-Milwaukee (UWM) School of Freshwater Science (SFS). The three
broodstocks chosen for the study were originally derived in 2006 from the gametes of
adult perch collected from three distinct locations: the Perquimans River of the
Albemarle Sound (NC), the Choptank River of the Chesapeake Bay (MD), and Lake
Winnebago (WI), a watershed connected to Lake Michigan by the Fox River. Thus, all
three stocks originated from three separate drainage basins and genetic analyses
confirmed that each represented a separate population (Grzybowski et al., 2010; Todd &
Hatcher, 1993). Since their origin, two subsequent generations of these broodstocks have
been produced from crosses within the stocks. Juvenile fish for the current study were
produced from the second generation of crosses and were reared under identical
environmental conditions at the UWM SFS Aquaculture Research Facility according to
the guidelines of the Animal Care and Use Committee of the UWM as previously
described (Rosauer et al., 2011).

Virus challenge
When the juvenile perch were 1-2g, they were transferred to the USGS Western
Fisheries Research Center in Seattle, WA and held for 6-8 weeks prior to virus challenge.
Choptank River perch were used in a preliminary experiment to determine the dose of

25

VHSV for subsequent challenges (data not shown) and optimal dose was determined such
that the full effect of the virus could be observed within 28 days post-infection. For the
main challenge experiment, all three stocks of fish were exposed to VHSV-IVb by static
water-borne immersion with aeration at the predetermined viral titre of 5 x 105 PFU mL-1
for 2 hrs at 30 fish per tank (30 L) in triplicate tanks (n=90 fish) per treatment group.
VHSV-IVb Great Lakes (isolate Muskie MI03) virus strain used in the challenge was
propagated using the Epithelioma papulosum cyprini (EPC) cell line (Fijan et al., 1983a)
and initial virus titre was determined by plaque assay (Batts & Winton, 2007). Initial
water temperature was 10°C and raised 0.5°C daily until it reached 12°C for the duration
of the 28 day experiment. Identical triplicate tanks of each fish stock serving as negative
controls, were exposed to the same volume of tris-buffered Eagle's minimum essential
medium (MEM-10) used to formulate the virus treatments at the same temperature
regime. All control and virus challenge treatments were observed for 28 days and fish
were fed every other day during the challenge. Dead fish were recorded and removed
daily from each of the tanks. All survivors were euthanized after 28 days with an
overdose of NaHCO3 buffered tricaine methanesulfonate (MS-222; Western Chemical
Inc.). All fish in the study were immediately frozen and stored at -80°C until virus
analysis could be performed.

Virus analysis by plaque assay
Virus titre was determined in a representative subset of 7 fish that had succumbed to
infection and 15 surviving fish from each yellow perch stock (total n= 66 fish, 22 fish
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stock-1). Whole fish were diluted 1:8 (weight:volume) in MEM-0 and homogenized with
a Stomacher-80 (Seward Laboratory Systems, Biomaster). Sample homogenates were
transferred into 15 mL conical tubes and spun at 4°C for 10 minutes at 1000 x g. One
milliliter (mL) of supernatant from each sample was removed to quantify infectious virus
by plaque assay, and another 1 mL stored at -80°C to assess virus genome concentrations
by qRT-PCR. For plaque assay, serial 10-fold dilutions (1:40 to 1:4 x 106) of tissue
homogenate supernatants were plated in duplicate onto polyethylene glycol (7% PEG)
treated EPC cell monolayers in 24-well plates. Cell-cultures were overlaid with
methylcellulose and incubated at 15°C for 7 days before fixation with crystal violetformalin solution and plaque enumeration as previously described (Batts & Winton,
1989a). Fish tissue viral titres of VHSV are reported as plaque forming units per gram
(PFU g-1).

Virus analysis by qRT-PCR
The qRT-PCR assay for the detection of VHS virus nucleic acids was developed and
described by (Garver et al., 2011). Thawed 210 µL samples of homogenate supernatant
were used for total RNA extraction using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s protocol. Complimentary DNA was synthesized from 1 µg RNA by RTPCR using the Applied Biosystems (ABI) High Capacity cDNA Reverse Transcription
kit according to the manufacturer’s protocol. VHS virus primers (Forward primer 5'ATG AGG CAG GTG TCG GAG G-3', Reverse primer 5'-TGT AGT AGG ACT CTC
CCA GCA TCC-3', Invitrogen) and MGB probe (5'-6 FAM-TAC GCC ATC ATG ATG
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ATG -MGBNFQ-3', ABI) were utilized for the qPCR assay as described in Garver et al.
(2011). The RNA standard used for qPCR virus quantification, generated by a plasmid
vector containing the N-gene of the virus, was generously provided by Dr. Kyle Garver
(Pacific Biological Station, Nanaimo, BC). RNA transcripts were quantified using a
NanoDrop ND-1000 and copy number was determined such that one µg of N RNA
transcript contained 1.32 x 1012 gene copies. A standard curve based on a dilution series
of N-transcripts ranging from 1 x108 to 1 x 101 viral gene copies was included on each
qPCR plate and used to calculate virus loads based on the resulting CT values. The
VHSV qPCR assay was performed using a LightCycler® 480 (Roche). Each qPCR assay
was conducted in a 25 µL reaction volume containing 1 µL of cDNA, 600 nM of each
primer, 200 nM probe, and 12.5 µL 2x TaqMan Universal PCR Master mix (Applied
Biosystems). The thermal cycle profile was: 2 minutes at 50ºC, 10 minutes at 95ºC, 40
cycles of 15 seconds at 95ºC, and 1 minute at 60°C (Garver et al., 2011).

Statistical analysis
Percent survival was calculated as the cumulative number of surviving fish in the
pooled triplicate tanks for each stock divided by the total number of fish for each stock
originally exposed to the virus x 100. All statistical analyses of % survival, multivariate
comparisons (ANOVA), and linear regression analysis on plaque assays and qRT-PCR
values were completed using Sigma Plot® software (Systat Inc.).
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Results
Clinical signs of VHSV infection
Clinical signs of VHS infection were similar among all three stocks of yellow perch
and included internal and external hemorrhages consistent with signs in other fish species
infected with VHSV. In addition to petechial hemorrhages observed throughout the body,
signs of hemorrhage were particularly visible on the brain and optical lobes when the fish
were viewed dorsally (Fig. 2-1A). Hemorrhage was also evident in the eye socket in
association with exophthalmia (Fig. 2-1B), and at the base of the pectoral and pelvic fins
(Fig. 2-1B & 2-1C). Internally, abdominal swelling as a result of severe ascites, and
petechial hemorrhages on the swim bladder and liver were commonly observed.

Survival among stocks
The cumulative number of survivors for each yellow perch stock was used to calculate
% survival (Fig. 2-2). In the VHSV exposed fish, yellow perch stocks from the East
Coast (Choptank River and the Perquimans River) were nearly identical in susceptibility,
with relatively high survival of 74% (67/90) and 73% (66/90), respectively. Alternatively,
the Midwest (Lake Winnebago) perch exhibited relatively low survival of 20% (18/90).
An initial Kaplan-Meier Log-Rank Survival Analysis as well as a pair-wise multiple
comparison test using the Holm-Sidak method demonstrated a significant (P = <0.001)
difference in % survival between Lake Winnebago and Choptank River fish, and between
Lake Winnebago and Perquimans River fish, but not between Choptank River and
Perquimans River fish (P= 0.735). This indicates that the yellow perch stocks originating
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from Lake Winnebago in Wisconsin were significantly more susceptible to Great Lakes
VHSV-IVb than perch originating from the two East Coast populations (Choptank River,
MD, Perquimans River, NC). In equivalent tanks of negative control fish, 99% (89/90) of
the Lake Winnebago and Choptank River fish and 94% (85/90) of the Perquimans River
fish survived the 28 day experiment.
When virus load was determined in subsamples of fish from each stock, the Lake
Winnebago fish that survived the challenge with VHSV had significantly higher virus
titres and viral N-gene copy numbers (ANOVA, P<0.05) then Choptank or Perquimans
River fish (Table 2-1). The prevalence of virus in the surviving VHSV exposed fish
differed as well. Only 4 of 15 Perquimans River fish and 8 of 15 Choptank River fish
tested positive for VHSV at the end of the 28-day challenge period, while 13 of 15
surviving Lake Winnebago fish had detectable virus titres verifiable by both plaque assay
and qRT-PCR. All VHSV exposed fish that died during the challenge had detectable
virus (100% prevalence) in all three stocks by both plaque assay and qRT-PCR.
Statistical analysis using ANOVA indicated no significant differences in detectable virus
loads in these fish. None of the negative control fish that died during the 28-day
challenge tested positive for VHS virus.
Differences between the three stocks of yellow perch were also apparent in the
kinetics of VHSV infection (Fig. 2-3). Fish from Lake Winnebago had an acute high
mortality response on day 9, followed by an even greater mortality response that peaked
on day 14, resulting in a bimodal disease progression pattern. The Choptank River perch
had a relatively delayed bimodal response to infection with the first peak in mortalities
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occurring on day 13 and the second mortality peak on day 21. The Perquimans River fish,
alternatively, were the first stock of fish to succumb to VHSV infection with a mortality
peak on day 4; however, a slow progression of the disease resulted in a wide-spread
temporal distribution of mortality.

A

B

C

Figure 2-1. Clinical signs affiliated with VHSV-IVb infection in three different juvenile
yellow perch after immersion exposure to the Great Lakes VHSV strain at a dose of
1x105 PFU mL-1. Hemorrhages were visible around the brain and optical lobes when the
fish were viewed dorsally (A), the eye socket (B), and at the base of the pectoral and
pelvic fins (B & C).
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Figure 2-2. The cumulative % survival of Lake Winnebago, Choptank River, and
Perquimans River perch after water-born exposure to VHSV-IVb.
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-1

Survivors (n = 15 stock )
Prevalence of VHSV
-1

PA titer (PFU g )
qRT-PCR (copy #)

Perquimans R.

Choptank R.

L. Winnebago

(4/15) 27%

(8/15) 53%

(13/15) 87%

64,784
1,860

26,483
1,473

1,367,489
86,231

(7/7) 100%

(7/7) 100%

(7/7) 100%

3,040,800
463,877

10,977,605
1,110,308

14,380,585
1,809,404

-1

Mortalities (n = 7 stock )
Prevalence of VHSV
-1

PA titer (PFU g )
qRT-PCR (copy #)

Table 2-1: Prevalence of VHSV (#VHSV positives over total # of fish examined) and
comparison of the geometric mean virus load by plaque assay (PA) and qRT-PCR.
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Daily Recorded Mortalities Post-VHSV IP-Injection

Daily Mortailities
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Figure 2-3. Kinetics of VHSV-IVb infection between Lake Winnebago, Choptank River,
and Perquimans River perch stocks.

Comparison between plaque assay and qRT-PCR
All whole fish (n=72) homogenates were analyzed for VHSV using both plaque assay
(PFU g-1) and qPCR (viral copy # µg-1 RNA). When results were directly compared after
a logarithmic transformation, a significant positive correlation between virus load as
determined by qRT-PCR and the corresponding number of plaques in paired samples was
found with a Pearson correlation coefficient of R2 = 0.89 (P < 0.001) (Fig. 2-4). The limit
of detection for the plaque assay was 500 PFU g-1, while the limit of detection for the
qRT-PCR assay was 10 viral copies; therefore, four of the samples contained a low level
of virus detectable by qPCR, but were negative by plaque assay.
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Log(PA) = -0.0171+(1.88 x Log(qPCR))
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R2 = 0.89
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Figure 2-4. Linear regression between plaque assay (PA-PFU g-1) and qRT-PCR (qPCRviral copy #) on log transformed data (R2 = 0.89). Thin dotted and dashed lines represent
the 95% confidence intervals for the population and regression, respectively.
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Discussion
This study identified major differences in susceptibility to the Great Lakes VHSV-IVb
strain in yellow perch populations originating from different genetic and geographic
origins. Because the environmental conditions for rearing and challenging the fish were
identical for all three stocks, genetic differences between the populations from which the
stocks were derived most likely contributed to the variability in virus susceptibility. In the
present study, the major differences in susceptibility were observed between fish from the
Lake Winnebago stock versus the two East Coast stocks from the Perquimans and
Choptank Rivers. While significant genetic differences were previously observed
between all three of the perch populations from which these broodstocks were derived, a
greater difference was observed between East Coast and Midwest perch populations than
between East Coast populations (Gryzbowski et al., 2010) supporting the results
observed here. In aquaculture, the identification of disease resistant stocks of fish is a
vital first step towards the development of healthier broodstocks. Because many disease
resistance traits have been shown to be heritable, there is large potential to continue this
form of genetic improvement within current fish broodstocks throughout the aquaculture
industry (Norris et al., 2008; Ødegård et al., 2011; Ødegård et al., 2007; Wetten et al.,
2007).
A previous study examining the three yellow perch stocks used in this study also
found significant differences in other phenotypes, such as growth (Rosauer et al., 2011).
The Lake Winnebago population had a significantly lower growth rate overall than both
Choptank River and Perquimans River fish. It has been proposed that, because growth
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and an active immune response are both resource-demanding processes, a trade-off
between fast growth and an effective immune response would most likely exist (Johansen
et al., 2006). In contrast, more recent studies evaluating the correlation between body
weight and disease resistance have demonstrated no such adverse relationship (Silverstein
et al., 2009). The results of these previous studies, as well as the results reported here,
imply that simultaneous genetic improvement for both growth and disease resistance can
be accomplished. Rosauer et al. (2011) also documented differences in apparent stress
level between Lake Winnebago, Choptank and Perquimans River stocks, which may be
linked to growth rate and the potential to resist infection. In the study by Rosauer et al.
(2011), it was reported that Lake Winnebago fish seemed more easily stressed by human
interactions (e.g., tank cleaning, adjusting feeders, and peering into or walking by the
tank), than Choptank or Perquimans River fish. This increased level of stress may lead to
lower growth rates and reduced resistance to infection.
An additional factor that may be affecting susceptibility is that fish from the Great
Lakes region may have never been exposed to VHS virus or any similar rhabdovirus in
the past, making them particularly vulnerable. Alternatively, the perch stocks from the
Choptank River and Perquimans River, both river estuary environments on the east coast
of the U.S., may have encountered strains of VHSV (Gagne et al., 2007) or other marine
viruses and, thus, natural selection would have allowed for the development of more
resistant stocks. Similar pathogen-driven selection mechanisms have been proposed for
disease resistance among different populations of Chinook salmon (Oncorhynchus
tshawytscha), which were comparable in genetic diversity, but separated by a
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geographical land barrier (Purcell et al., 2008). Alternatively, marine populations of
Pacific herring (Clupea pallasii) with distinct genetic differences and similarly high
diversity were found equally susceptible to the North American marine strain of VHSVIVa (Hershberger et al., 2010) possibly due to similar selection pressures of a shared
environment.
The clinical signs observed in the infected perch were similar to signs of VHS virus in
other species, including septicemic hemorrhages throughout the body and at the base of
the fins. The transparency of dead juvenile perch allowed us to observe severe internal
haemorrhages around the lobes of the brain, suggesting that infected fish may suffer
permanent damage to the central nervous system and that the brain may be a potential
viral reservoir in surviving fish.
The plaque assay currently remains the 'gold standard' for the verification of infectious
virus and is the best method for the detection of infectious virus particles. The plaque
assay, however, is also relatively labor intensive, time consuming (requires a minimum of
5 days to complete), and the resulting titre can be highly susceptible to the presence of
proteolytic enzymes, the quality and quantity of the cell monolayer used in the assay,
changes in temperature, and differences in incubation time. Alternatively, quantitative
reverse transcription-polymerase chain reaction (qRT-PCR) has become an increasingly
common method for the diagnosis of a wide variety of viruses due to its speed (a large
number of samples can be analyzed in <1 day) and sensitivity (detection of less than 10
copies of RNA target genes can be achieved). It has become particularly useful in the
medical diagnosis of other RNA viruses, including Ebola and Marburg viruses, Lassa
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virus, Crimean-Congo haemorrhagic fever virus, Rift Valley fever virus, dengue virus,
and yellow fever virus (Drosten et al., 2002). Unlike the plaque assay, this method can be
used to detect all viral RNA, not just infectious particles. This is particularly useful in the
detection of a negative-strand RNA rhabdovirus such as VHS virus, where the mutation
rate and thus the presence of non-infectious particles and RNA is typically much higher
than that of other viruses (Flint et al., 2004). However, in most cases, the detection of
viral RNA by qRT-PCR is only an indicator of infection, and provides no information
regarding the infectious capabilities of the virions detected. Only a few studies have
worked towards identifying the relationship between qRT-PCR and plaque assay analysis
of the VHS virus in fish (Chico et al., 2006; Garver et al., 2011; Hope et al., 2010). Here,
we directly compared VHS virus concentrations in whole fish by plaque assay using cell
culture and qRT-PCR using primer/probe sets designed by Garver et al. (2011) to test
whether a correlation between the two methodologies could be observed.
The strong positive correlation between the VHSV qRT-PCR and plaque assays
results suggests that the viral copy number as determined by the qRT-PCR assay of
Garver et al. (2011) is directly correlated to levels of replicating virus and can be used
together in virus screening practices. Although not true for all viruses, a similar
correlation between qRT-PCR (viral copy #) and plaque assay (PFU g-1) was also
identified for the detection of the RNA virus responsible for yellow fever (Bae et al.,
2003), and qRT-PCR is currently used to estimate the titre of infectious measles, mumps,
and rubella in live virus vaccines (Schalk et al., 2005; Schalk et al., 2004).
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In this present study, four fish had detectable virus by qRT-PCR that was undetected
by plaque assay (Figure 2-4). While a negative plaque assay result indicates that any
infectious virus present was below the limits of detection, qRT-PCR confirmed the
presence of viral RNA in these fish. Because these four samples represented surviving
fish from the 28-day viral challenge, this may mean that either the fish have successfully
cleared the virus, or that latent virus may still be present but below the detection limit of
the plaque assay. In either scenario, the indication of viral RNA may still warrant further
evaluation of the fish as a potential viral reservoir of latent infection, or may simply
indicate previous exposure to the virus.
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" The recently discovered strain of viral hemorrhagic septicemia virus, VHSV-IVb,
represents an example of the introduction of an extremely pathogenic rhabdovirus
capable of infecting a wide variety of new fish species in a new host-environment. The
goal of the present study was to delineate the expression kinetics of key genes in the
innate immune response relative to the very early stages of VHSV-IVb infection using the
yellow perch (Perca flavescens) as a model. Administration of VHSV-IVb by IP-injection
into juvenile yellow perch resulted in 84% cumulative mortality, indicating their high
susceptibility to this disease. In fish sampled in the very early stages of infection, a
significant up-regulation of Mx gene expression in the liver, as well as IL-1β and SAA
activation in the head kidney, spleen, and liver was directly correlated to viral load. The
potential down-regulation of Mx in the hematopoietic tissues, head kidney and spleen,
may represent a strategy utilized by the virus to increase replication."
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Introduction
Due to its extremely has a long history as being one of the most pathogenic viral
diseases of finfish worldwide (Skall et al., 2005; Smail, 1999; Wolf, 1988)Outbreaks of
the highly pathogenic fish virus, viral hemorrhagic septicemia virus (VHSV) are
characterized by systemic hemorrhage throughout the body of the fish and mortality rates
that can be as high as 90% in a wide number of host species. The causative agent of VHS
is a negative-sense RNA virus (VHSV) belonging to the family Rhadboviridae, and
classified in the genus Novirhabdovirus (ICTV, 2012). Because of its severe impact on
trout farms in Western Europe, the virus has been historically considered a European fish
pathogen exclusively targeting freshwater salmonids. Thus, the majority of viral-host
interaction studies have been conducted on the rainbow trout (Oncorhynchus mykiss).
More recent phylogenetic analyses of VHSV isolates from a large number of marine fish
species in the Atlantic and Pacific Oceans, however, have identified VHSV as essentially
a marine virus in origin and categorized VHSV isolates into four genotypes (I, II, III, and
IV) (Einer-Jensen et al., 2004; Pierce and Stepien, 2012; Smail, 1999). These findings
suggest that the marine to freshwater species host-jump associated with the virus's ability
to exclusively infect salmonids in Europe in the 1900s was due to repeated introductions
of the virus into salmonid stocks through anadromous migration or, more likely, via the
practice of feeding raw, infected marine fish over a long period of time (Kurath and
Winton, 2011). Therefore, the emergence of a freshwater VHSV genotype IVb in the
Great Lakes basin of North America (Elsayed et al., 2006), emphasizes the ability of this
RNA virus to once again adapt from a saltwater to a freshwater environment, however,
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the causal mechanisms of this adaptation remain unknown. Unlike the rainbow trout
adapted strain of VHSV in Europe (genotype VHSV-Ia), the Great Lakes strain of
VHSV-IVb has also demonstrated the ability to infect a very large number of new host
species in a relatively short amount of time (Ammayappan & Vakharia, 2009; Kim &
Faisal, 2010b; Thompson et al., 2011b). Since its discovery, questions and concerns
regarding the ability of the virus to spread rapidly throughout the inland waters of the
U.S. and infect naive populations of freshwater fish are being addressed (Kim & Faisal,
2010b; Kim & Faisal, 2011).
The yellow perch (Perca flavescens) is a freshwater species of fish that has been a part
of large fish kills in the Great Lakes associated with VHSV-IVb, and is listed as a
susceptible species to the virus (USDA, 2008). Therefore, the potential impact that
VHSV could have on yellow perch commercial and sport fisheries is of great concern to
fisheries and aquaculture managers (Kane-Sutton et al., 2010). The yellow perch,
however, is also a fish species in which the physiological and immune responses to viral
infection have not been well studied and, thus, are poorly understood. Most of the
research on the host response to VHSV has been completed on the rainbow trout, an
ancestral teleost salmonid species. However, the yellow perch is a more derived teleost,
in which differences in the antiviral immune response may have evolved over time.
Vaccine development, the enhancement of feed immunostimulants, and the development
of hardier, more disease resistant fish stocks, are some of the potential strategies
proposed to mitigate the impact that VHSV-IVb will have on fisheries and aquaculture
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populations. To accomplish any of these disease prevention strategies, however, requires
an understanding of the host immune defenses involved.
Many studies have demonstrated that the most successful vaccines against virus
diseases of fish will confer a non-specific anti-viral response at early stages postvaccination (Lorenzen et al., 2002; McLauchlan et al., 2003). It has also been observed
that the successful activation of non-specific innate defense mechanisms induced shortly
after infection will often determine the outcome, or survival of the fish, after viral
exposure. Thus, to better understand the fish host-virus relationship between the VHS
IVb virus and its naive freshwater hosts, the present study focuses exclusively on the
early innate immune pathways triggered relative to viral load by VHSV-IVb infection
during the very early stages of infection.
While a large repertoire of complex pathways and molecules are involved in the early
innate immune response, the expression of Mx, interleukin 1β (IL-1β), and serum
amyloid A (SAA), representative cytokines that function in three different components of
the fish's innate immune system, were the focus in the current study. The expression of
the Mx transcript has become a direct indicator of type I interferon (IFNα and IFNβ)
activation, a crucial component of the antiviral innate immune response conserved in
many species. Interleukin-1β is a pro-inflammatory cytokine that has been implicated as a
key gene in early VHSV infection in rainbow trout (Tafalla et al., 2005). In mammals,
SAA is primarily synthesized in the liver and induced by the inflammatory cytokines
interleukins 1 and 6 and tumor necrosis factor (Thorn & Whitehead, 2002). In salmonids,
SAA induction has been well documented in the liver upon bacterial infections and
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stimulation with various pathogen-associated molecular patterns (PAMPs) (Bayne &
Gerwick, 2001; Jensen et al., 1997), however, SAA transcription and up-regulation have
also been described in rainbow trout macrophages in response to lipopolysaccharide
(Goetz et al., 2004), and the skin of parasite-infected carp (Gonzalez et al., 2007). The
results of this study increase not only our understanding of the antiviral mechanisms
utilized by a more recently evolved fish species to a novel virus, but provides insight into
the anti-viral role these cytokines may play in lower vertebrates such as the yellow perch.

Materials & Methods
Yellow Perch, VHSV Propagation, and Intraperitoneal-Injection Challenge
Juvenile yellow perch were obtained from the University of Wisconsin-Milwaukee
(UWM) School of Freshwater Science (SFS). All fish used in the study were originally
derived from spawnings of yellow perch broodstocks collected as gametes from the
Choptank River, MD, and reared under identical environmental conditions at the UWM
SFS Aquaculture Research Facility according to the guidelines of the Institutional
Animal Care and Use Committee (IACUC) of the UWM as previously described
(Rosauer et al., 2011). The fish used in the current study were offspring from the second
generation of fish derived from the Choptank River broodstock. When the juvenile perch
were approximately 5-10g, they were transferred to the USGS Western Fisheries
Research Center (WFRC), Seattle, WA, where they were reared and used for the
subsequent challenge experiment under protocols approved by the IACUC of the WFRC.

49

All virus exposure experiments were performed in the WFRC aquatic biosafety level-3
containment laboratory.
The Great Lakes VHS virus strain IVb (MI03) was isolated from adult muskellunge,
Esox masquinongy (Mitchill) from Lake St. Clair in 2003 (Elsayed et al., 2006). The
virus was propagated using the Epithelioma papulosum cyprini (EPC) cell line (Fijan et
al., 1983b) and concentration determined by plaque assay as previously described (Batts
& Winton, 2007)
For the challenge experiment, 100 fish (7-10g) were equally divided into four tanks,
each containing 25 fish, and exposed to the VHSV by intraperitoneal (IP) -injection at a
titer of 1 x 105 PFU/fish. Four additional tanks, each containing 25 fish, served as
negative control groups, and were challenged by IP injection with the same volume of
tris-buffered Eagle's minimum essential medium (MEM-10-T) used to formulate the
virus treatments to simulate the stresses of handling and injection. Water temperature was
9°C at the start of the challenge and then raised 1.0°C daily until it reached 12°C. All fish
were fed every other day throughout out the entire challenge experiment. Of the negative
control tanks and virus challenged tanks, fish from one tank in each group were
monitored daily for a total of 17 days only for mortality events to assess disease
progression. From these tanks, dead fish were removed daily and mortality data recorded.
Percent survival in each tank was calculated as the cumulative number of surviving fish
divided by the total number of fish x 100. In the other three virus and negative control
treatment tanks, four fish were lethally sampled from each tank on days 1, 2, 3, 4, 5 and 6
post-virus exposure (n=12 fish/treatment group/day) (Figure 1). Each fish sampled was
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euthanized by an overdose (25 mg mL-1) of buffered tricaine methanesulfate (MS-222,
Western Chemical Inc.), and the liver, spleen, and head kidney were collected into
RNAlater (Qiagen) and kept at -80°C until RNA extraction.

cDNA synthesis
Tissues stored in RNAlater were weighed and transferred into Qiagen Lysis Buffer for
homogenization using lysing matrix D beads (MP Biomedicals). Total RNA was isolated
from the homogenized tissue using the RNAqueous®-Micro Scale RNA Isolation Kit
(Ambion) according to the manufacturer’s protocol that included a 20-minute in column
DNase treatment. Total RNA quality and concentration were determined using a Bio-Rad
Experian Electrophoresis Station. All RNA used in the study had a RNA Quality
Indicator (RQI) value >7.0 and a 260/280 index of 2.00 ± 0.20. Complimentary DNA
was synthesized using an oligo-dT-primer and ImProm-II Reverse Transcriptase kit
(Promega) according to the manufacturer’s protocol. The thermal cycle profile was: 25°C
for 5 min., 42°C for 1 hr., 70°C for 15 min., and a 4°C hold.

Gene Expression Analysis by qPCR
The expression of Mx, IL-1β, and SAA was quantified by real time quantitative
reverse transcription PCR (qRT-PCR) using Power SYBR Green PCR Master Mix
(Applied Biosystems), cDNA and gene specific primer sets (Table 1) on either a
Stratagene Mx 3000P qPCR system or a LightCycler® 480 (Roche) and analysis was
completed with Real-time PCR Miner software (Zhao & Fernald, 2005). Quantification
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was performed by calculating the relative mRNA concentration (Ro) for each gene per
individual sample using the following equation: Ro = 1/(1+E)Ct, where E is the gene
efficiency calculated as the average of all individual sample efficiencies across all
reactions for a given gene per qPCR, and Ct is the cycle number at threshold (Zhao &
Fernald, 2005). Gene expression analysis in all fish (virus-exposed and mocks) was
normalized to the control genes, ribosomal S4 (RS4) in the head kidney and liver, and
elongation factor-α (EF-1α) in the spleen (Table 1). Elongation factor-α, rather than RS4,
was used as a normalizing gene in the spleen since RS4 expression in the spleen was
found to change relative to VHSV detection. To determine the level of gene regulation,
transcript expression of virus-exposed fish was quantified relative to transcript expression
in negative control fish.

Virus load by qRT-PCR
To assess the amount of VHSV in infected fish, we used the qRT-PCR protocol
described by Garver et al. (2011). The RNA standard used for qPCR virus quantification
generated by a plasmid vector containing the N-gene of the virus was generously
provided by Dr. Kyle Garver (Pacific Biological Station, Nanaimo, BC). The VHSV
qPCR assay was performed using a Stratagene Mx 3000P qPCR system (Roche). Each
qPCR assay was conducted in a 25 µl reaction volume containing 1 µl of cDNA, 600 nM
of each primer, 200 nM probe, and 12.5 µl 2x TaqMan Universal PCR Master mix
(Applied Biosystems) (Table 3-1). The qPCR cycle profile was: 2 min at 50ºC, 10 min at
95ºC, 40 cycles of 15 sec at 95ºC, and 1 min at 60°C (Garver et al., 2011). A standard

52

curve based on a dilution series of N-transcripts ranging from 1 x108 to 1 x 101 viral gene
copies was included on each plate and used to calculate virus loads based on the resulting
CT value.

Statistics
Statistical relevance was calculated using Sigma Plot® software (Systat Inc.).
Statistical analysis of gene expression relative to time of expression and tissue type was
completed using Tukey's pairwise multivariate comparisons procedure within a two-way
analysis of variance (ANOVA). Correlation results were completed using linear
regression analysis on log transformed data.

Genebank
accession #/
Source

Gene

5'- Forward-3'

5'- Reverse-3'

Size of PCR
product (bp)

IL-1β

ATC TTG AGG TTG TGG AGG CA

GCA CAT TTC CAC TGG CTT GT

176 bp

GO656767.1

Mx

AAG AGG CAG TGG CAT TGT

AAT GAG CGT CAG GTC TGG AA

244 bp

GO654167.1

SAA

ACC ATG CTC GTT TGC CTT CT

TGT GGC GAG CAT ACA GTG AT

209 bp

KC306947

EF-1α

TGA CAA CGT CGG CTT CAA CA

GCA CAT TTC CAC TGG CTT GT

124 bp

GO658156.1

RS4

ACA TCA CCT ACC CTG CTG GAT T

AAT GCC CTT GGT GCC AAT CA

174 bp

FK819484.1

VHSV

ATG AGG CAG GTG TCG GAG G

TGT AGT AGG ACT CTC CCA GCA TCC

82 bp

Garver et al. 2011

MGB probe

5'-6 FAM-TAC GCC ATC ATG ATG - MGBNFQ-3'

Table 3-1. Yellow perch primers used for immune gene expression analysis and VHSV
(N-gene) primer (Garver et al. 2011).
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Results
Clinical Signs and Progression of VHS in Yellow Perch
External signs were only noted on the fish that had succumbed to the disease in the
mortality monitoring tanks and most typically included petechial hemorrhages throughout
the entire body as well as exophthalmia (Figure 3-1.). In the tanks reserved for
monitoring mortality events, the first documented death occurred on day 9 post-VHSV
injection, three days after the last sampling date in the experiment (Figure 3-2). Total
mortalities within this tank peaked on day 11. At the end of the 17-day challenge period,
cumulative mortality was 84% (21/25). No deaths occurred in the negative control tank.
No fish, VHSV-exposed or mock treated, died in tanks used to assess disease progression
during the six-day sampling period of the experiment. Clinical signs of disease as
hemorrhage of the internal organs and moderate to severe ascites were first documented
within fish on days 5 and 6 post-VHSV injection.

Figure 3-1. The clinical signs observed in yellow perch that succumbed to VHS infection
by VHSV-IVb IP-injection included petechial hemorrhage throughout the entire body of
the fish as well as exophthalmia within the eye sockets.
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Figure 3-2. Daily mortalities recorded over a 17-day period post-virus challenge. Fish
were sampled for gene expression and viral load on days 1-6 (arrows) post-virus injection
before any mortality had occurred to capture the early innate immune response to
infection.
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VHS Viral Load in Tissues
The VHSV N-gene copy number was measured separately in each of the three tissues
within each fish sampled (N=54 fish) post-VHSV injection by qRT-PCR, and the
geometric mean of detected viral load (copy #) was analyzed over time. Significant
increases in viral load were observed in all three tissues on days 3, 5 and 6 relative to day
1. While the accumulation of viral RNA was directly correlated with time post-challenge
in all three tissues (P < 0.001), the accumulation of virus was the most rapid and
significantly correlated with time within the spleen (F (1, 52) = 66.61, R2 = 0.56) (Figure 33); however, differences in the total viral load measured in the head kidney and spleen
were not significant on any of the sampling days. Total viral load remained lowest in the
liver. Because of a more rapid accumulation of virus within the head kidney and spleen,
virus load detected in these organs became significantly greater than virus load detected
in the liver by day 6 of the challenge (Figure 3-4).
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57

Mx Gene Expression
Mx gene expression within the tissues of VHSV infected fish was measured and
analyzed relative to expression in the tissues of control fish on each of the six sampling
days (Figure 3-5). The expression of Mx in the tissues of the control fish averaged 0.041
(± 0.017) in the head kidney, 0.086 (± 0.053) in the spleen, and 0.0046 (± 0.0045) in the
liver. Mx expression in the head kidney of VHSV-exposed fish peaked at a 6.5-fold
increase relative to Mx expression in control fish on day 4 post-VHSV injection, and
remained relatively unchanged on days 5 and 6, at a 6.4- and 6.2-fold increase,
respectively. Mx expression in the spleen of VHSV-injected fish gradually increased and
peaked at a 7.0-fold increase relative to the control fish on day 5 post-VHSV injection.
On day 6 post-VHSV injection, Mx expression in the spleen declined to a 0.5-fold level
relative to Mx expression in the control fish. Mx expression in the liver, alternatively,
was significantly elevated relative to controls on day 6 post-VHSV injection (P < 0.001),
as well as to levels in the head kidney and spleen on days 4-6 post-VHSV injection (P <
0.05). A linear regression analysis indicated that no significant correlation between Mx
expression and virus load was found in either the head kidney or the spleen (Figure 3-6).
Mx expression in the liver, however, was significantly correlated to viral load (P < 0.001,
F(1,41) = 56.46, R2 = 0.58).
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Figure 3-5. Mx gene expression (relative to mock-infected control fish) in head kidney,
spleen and liver on days 1-6 post-VHSV injection. Single asterisks indicate significant
increases in Mx expression in the liver on days 4, 5 and 6 relative to day 1. Double
asterisks indicate significant differences in Mx expression between spleen and head
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IL-1β Gene Expression
Il-1β gene expression within the tissues of VHSV infected fish was measured and
analyzed relative to expression in the tissues of control fish on each of the six sampling
days (Figure 3-7). The expression of IL-1β in the tissues of the control fish averaged
0.001 (± 0.0008) in the head kidney, 0.002 (± 0.0004) in the spleen, and 0.0001 (±
0.0001) in the liver. Within each of the tissues, IL-1β gene expression in the head kidney
peaked on day 3 with a 74- fold increase relative to the control before decreasing to 27fold and 30-fold increases on days 5 and 6 post-VHSV injection, respectively. IL-1β gene
expression in the spleen peaked on day 4 with a 122-fold increase relative to the control
before decreasing to a 31-fold increase one day later. The expression level on day 4 was
significantly higher relative to days 1, 2, 3, 5 & 6 (P < 0.05). IL-1β gene expression in the
liver peaked on day 5 with a 173-fold increase relative to the control before decreasing to
a 36-fold increase on day 6 post-VHSV injection. The expression level on days 4 and 5
were significant relative to days 1, 2, 3 & 6 (P < 0.05). Overall, IL-1β gene expression
within the tissues of VHSV-injected fish was significantly correlated with viral load in all
three tissues (P<0.001) (Head Kidney: F (1, 41) = 41.21, R2 = 0.50; Spleen: F (1, 43) = 26.93,
R2 = 0.39; Liver: F (1, 43) = 35.23, R2 = 0.45) (Figure 3-8).
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SAA Gene Expression
SAA gene expression within the tissues of VHSV infected fish was measured and
analyzed relative to constitutive expression maintained in the tissues of control fish on
each of the six sampling days (Figure 3-9). The expression of SAA in the tissues of the
control fish averaged 0.0007 (± 0.0006) in the head kidney, 0.014 (± 0.014) in the spleen,
and 0.087 (± 0.046) in the liver. SAA expression gradually increased over time and
peaked on day 6 in all three tissues, with a 12.2-fold increase in the head kidney, a 42.6fold increase in the spleen, and a 119-fold increase in the liver. Significant increases in
SAA expression were identified on days 4, 5, & 6 in the liver and day 6 in the spleen (P ≤
0.05) (Figure 3-9). SAA expression was also significantly correlated with viral load in all
three tissues (P<0.001) (Head Kidney: F (1, 38) = 135.83, R2 = 0.78; Spleen: F (1, 38) =
89.48, R2 = 0.70; Liver: F (1, 40) = 81.41, R2 = 0.67) (Figure 3-10).

Discussion
An increasing number of studies have focused on the early innate immune response to
the virus as a key factor controlling the outcome of infection. Past studies on the immune
response to VHSV have focused primarily on rainbow trout and the response to virus
isolates of genotype VHSV-I, II, and III. In contrast, the current study investigated the
viral accumulation and innate immune response towards an emerging invasive virus,
VHSV-IVb, in yellow perch, a percid phylogenetically distant from salmonids and
relatively unstudied compared to rainbow trout. In this study, the administration of
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VHSV-IVb by IP-injection into juvenile yellow perch resulted in 84% mortality,
indicating their high susceptibility to this disease. In fish sampled in the very early stages
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Figure 3-9. SAA gene expression (relative to mock-infected control fish) in head kidney,
spleen and liver on days 1-6 post-VHSV injection. Single asterisks indicate significant
increases in SAA expression in the liver on days 4, 5 and 6 relative to day 1 and in the
spleen on day 6 relative to day 1.
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of infection, a significant up-regulation of Mx gene expression in the liver, as well as IL1β and SAA activation in the head kidney, spleen, and liver was directly correlated to
viral load. In addition, the relatively low level of Mx expression observed in the
hematopoietic tissues, head kidney and spleen, may represent the host response to a
strategy utilized by the virus to down-regulate or block Mx expression in these tissues,
thus increasing virus replication.
When the kinetics of viral RNA accumulation was monitored in each of the three
tissues, the accumulation of virus was the most rapid and significantly temporally
correlated within the spleen and head kidney. Even so, viral load also remained highly
correlated with time in the liver, suggesting that the liver might have a secondary role in
VHSV-IVb infection. Since the spleen and head kidney are the primary producers of
hematopoietic cells, including mature macrophages in fish, these results also suggest that
cells in these tissues may be specifically targeted and critical for successful VHSV
replication.
Mx proteins comprise a small family of GTPases and have been shown to induce a
high degree of resistance against virus infections in a number of vertebrates (Haller et al.,
2007), and even in the abalone (Haliotis discus), an invertebrate mollusk (De et al.,
2007). Mx genes, however, are highly polymorphic and the resulting amino acid
differences account for a large number of allelic gene products and a large degree of
variation between species, complicating their study. The presence of multiple isoforms of
Mx suggests that different protein products, with and without antiviral mechanisms, may
be unique to each species, and thus heavily influenced by the environment in which a
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species has evolved over time. In fish, for example, three isoforms of Mx have been
identified in rainbow trout (Trobridge et al., 1997; Trobridge & Leong, 1995), Atlantic
salmon (Salmo salar)(Robertsen et al., 1997), rock bream (Oplegnathus fasciatus)(Zenke
& Kim, 2009), and Gilthead seabream (Sparus aurata) (Fernandez-Trujillo et al., 2011),
seven in zebrafish (Danio rerio)(Altmann et al., 2004), five in the channel catfish
(Ictalurus punctatus)(Plant & Thune, 2008), two in the Atlantic halibut (Hippoglossus
hippoglossus)(Jensen & Robertsen, 2000), turbot (Scophthalmus maximus) (Abollo et
al., 2005), and goldfish (Carassius auratus)(Zhang et al., 2004), and one in the pufferfish
(Takifugu rubripes)(Yap et al., 2003), Japanese flounder (Paralichthys olivaceus)(Lee et
al., 2000), Senegalese sole (Solea senegalensis)(Fernandez-Trujillo et al., 2006), orangespotted grouper (Epinephelus coioides)(Chen et al., 2006), and barramundi (Lates
calcarifer) (Wu et al., 2010).
Contrary to similar studies examining Mx activation in rainbow trout (McLauchlan et
al., 2003), the present study identified a relatively high level of Mx expression in the
perch liver that while directly correlated to viral load, appeared to be associated with
relatively poor protection against VHSV disease progression (84% mortality). Unlike the
rainbow trout study, however, which examined the antiviral response of three Mx genes,
only one Mx gene was analyzed in this study, thus it may be possible that alternate forms
exist in perch with different expression kinetics. The sequences used to obtain qPCR
primers for this Mx form were obtained from a yellow perch expression sequence tag
(EST; Accession #GO654167.1), derived from sequencing the ovary. This EST contains
only a partial open reading frame so it is not possible to determine the precise Mx form
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that it represents. However, the amino acid sequence of this open reading frame aligns
most closely with an Mx protein from Perca fluviatilis, the European perch (Staeheli et
al., 1989). Only one Mx form was reported for P. fluviatilis but there was no attempt to
look for multiple forms so it may be possible that alternate forms exist in perch.
Alternatively, lower levels of Mx transcription and no correlation to viral load were
observed in the head kidney. Further, no correlation and even potential down-regulation
of Mx was observed in the spleen where virus accumulation was highest. These
observations may be due to interferon down-regulation as part of a strategy utilized by
the virus for enhanced replication within these tissues.
The pro-inflammatory cytokine IL-1β has also been well-characterized in a wide
variety of fish species and directly correlated to early viral infection in rainbow trout
(Purcell et al., 2010; Tafalla et al., 2005), although the role of IL-1β function in antiviral
defenses remains largely unknown. Allelic variations of IL-1β in fish suggest alternative
unknown functions may also exist, the activation of specific immune responses including
the induced expression of COX2 and MHC II in rainbow trout macrophages (Iliev et al.,
2005), as well as the in vivo enhancement of phagocytosis and increased resistance
against bacterial infections have been observed (Secombes et al., 2011).
IL-1β was significantly correlated to viral load in all three tissues though the duration
of the experiment, peaking at different stages of the infection within different tissues. The
kinetics of IL-1β activation were very different than those observed in a similar study
examining IL-1β expression in tissues of the rainbow trout after exposure to a very low
level of VHSV-Ia infection induced by IP-injection (Tafalla et al., 2005). In the rainbow
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trout, IL-1β activation was immediately induced (days 1 & 2 post-VHSV infection)
before returning to control levels by day 3 in the spleen. In addition, IL-1β was only
slightly activated in the head kidney and liver. In contrast, in the yellow perch, IL-1β
expression peaked at much higher levels later (days 3, 4, & 5 post-VHSV exposure) in
each of the tissues, particularly the liver, before a rapid down-regulation. In addition, IL1β was significantly correlated to viral load throughout the duration of the experiment.
The differences observed here may again be due to the heightened susceptibility of
yellow perch to the VHS virus, and suggest this inflammatory cytokine plays a significant
role in the disease progression.
Of the three genes analyzed, SAA activation was the most strongly correlated with
viral RNA accumulation, particularly in the head kidney, although SAA expression
reached its highest levels in the liver. This appears to be the first published report of SAA
activation directly tied to anti-VHSV immune response in fish. Human SAA is an acutephase protein that circulates in the blood and is known to be primarily synthesized in the
liver. It has been implicated in antiviral immune defense against hepatitis C virus by
inhibiting viral entry into cells (Cai et al., 2007; Lavie et al., 2006), as well as numerous
other immune defense functions ranging from cytokine activation (Patel et al., 1998), to
leukocyte recruitment (Mullan et al., 2006), and antimicrobial activity (Badolato et al.,
2000). The extrahepatic production of anti-viral SAA proteins in the plasma has been
observed in a variety of mammalian species (Urieli-Shoval et al., 1998). However, a
recent study examining SAA in rainbow trout challenged with bacterial proteins, found
significant up-regulation of SAA expression in immune relevant tissues, but no SAA
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proteins were detected in the blood or plasma, suggesting that in fish, a more localized
alternate function may exist (Villarroel et al., 2008). The results of the present study
support this hypothesis, that SAA may have a more localized, anti-viral role in all three
immune tissues of the yellow perch.
In summary, we present evidence that yellow perch mount a strong innate immune
response to VHSV-IVb as demonstrated by significant changes in the expression of IL1β, Mx and SAA in various immune related tissues during the early stages of VHSV
infection. Further, VHSV accumulation was highest and most directly correlated to SAA
expression in the spleen and head kidney, suggesting that SAA activation in these tissues
may be a direct indicator of VHSV-IVb infection. The continued study of emerging
viruses in non-traditional fish species, such VHSV-IVb in yellow perch, can provide
valuable insight into alternative immunological host defenses, as well as novel strategies
utilized by a rapidly evolving virus. Such knowledge is beneficial, not only for the
mitigation of the impact VHSV-IVb and similar viruses in aquaculture and fisheries, but
for our own understanding of the evolution of host-virus immune defenses.
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Chapter 4

Viral distribution and pathology of the Great Lakes viral hemorrhagic septicemia
virus (VHSV-IVb) in adult yellow perch

"Since the discovery of VHSV-IVb in the Great Lakes of North America, over 31
species of freshwater fish commonly found throughout the inland waters of the U.S. have
been classified as being susceptible to the disease. While studies have begun to examine
viral tissue distribution and pathology using highly susceptible juvenile fish, the goal of
this study was to better understand the viral pathogenesis as an infection progresses over
time in asymptomatic adult fish. Adult yellow perch (Perca flavescens) were exposed to
VHSV-IVb by IP-injection at two different titers, 1 x 102 PFU/fish and 1x104 PFU/fish
and sampled for viral tissue distribution. These titers produced infections that resulted in
67% and 60% cumulative survivals, respectively, with the onset of mild to no clinical
signs of the disease. Plaque assays on the tissues from VHSV-injected fish sampled over
the course of 28 days, revealed that virus was detected mainly in the gills as well as the
pooled head kidney and spleen. VHSV titers determined by qPCR detected viral load in
the blood that was highly correlated to viral detection in the pooled head kidney and
spleen over all sampling days, while viral load in the brain gradually increased over
time. Fluorescent microscopy imaging of brain tissues of VHSV-exposed fish at 28 days
indicated mild hemorrhage with VHSV-associated erythrocytes, as well as leukocytes,
and heavy infection in cell body layers within the optic tectum and in axonal tracts
throughout the brain. These results suggest that blood is an active component of VHSV
transport, and that the analysis of gills by plaque assay, and blood by qPCR, may offer
reliable and accurate methods of non-lethal sampling for VHSV in adult fish. These
results also indicate, however, that the brain of the fish may be a target organ of the virus
and heavy staining of VHSV in neurons suggest that the VHSV-IVb virus may be
neurotropic as well as hemorrhagic."

76

Introduction
Viral hemorrhagic septicemia virus (VHSV) is a fish virus best known for its severe
pathology and high mortality rates in rainbow trout (Oncorhynchus mykiss) hatcheries
throughout Europe, where outbreak of disease has resulted in extensive economic losses
since its discovery in 1962 (Einer-Jensen et al., 2004; Olesen, 1998; Skall et al., 2005;
Smail, 1999; Wolf, 1988). Because potential outbreaks of this highly transmissible virus
have had such profound socio-economic consequences, the Office of International
Epizooties (OIE), also known as the World Organization of Animal Health, has
categorized VHSV as a reportable disease of great international concern. Thus, the
increasing number of aquatic environments in which the virus has been found is of great
concern to fisheries and aquaculture managers throughout the world. With the exception
of the VHSV-Ia strain, VHSV was typically known as a marine virus until a new
freshwater strain, now classified as VHSV-IVb, was reported in 2005 in the Great Lakes
of North America from adult muskellunge sampled in 2003 (Elsayed et al., 2006). Since
then, the VHS virus has been found capable of infecting over 31 species of freshwater
fish commonly found throughout the inland waters of the U.S. (Kim & Faisal, 2010b;
Thompson et al., 2011b). Never before had VHSV, or any other rhabdovirus been
isolated in any of the Great Lakes, reflecting the ability of VHSV to rapidly evolve into a
new-host environment (Pierce & Stepien, 2012), and opening the door for a large number
of new freshwater host-species to become infected with the virus.
Genotypic analysis has classified VHSV as part of the Rhabdoviridae family, which
includes some of the most well-known and most well-studied mammalian viruses, rabies
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and vesicular stomatitis virus (VSV). Like all rhabdoviruses, VHSV is a negative-strand
RNA virus consisting of an 11.2 kb nucleotide genome which includes five proteins
including, the nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein
(G), and the viral RNA polymerase (L). Unique to VHSV and other fish rhabdoviruses,
however, is a unique sixth gene that encodes a non-virion (NV) protein of unknown
function. This non-virion protein is expressed in infected cells but is not present in
purified virions (Kurath et al., 1997), and has resulted in the placement of fish
rhabdoviruses into of the newly recognized Novirhabdovirus genus within the
Rhabdoviridae family.
Clinical signs of an acute VHS manifestation of the disease in fish are often nonspecific, appearing as petichial hemorrhages throughout the body, hemorrhaging at the
base of the fins, muscles, internal organs and eyes, exophthalmia, darkening of the body
and pale gills. Ascites and hemorrhaging of the liver and other internal organs are often
observed upon necropsy (Kim & Faisal, 2010a; Olson et al., 2013; Wolf, 1988). In acute
forms of the disease, mortality is rapid and commonly as high as 100% in juvenile fish,
and as much as 30-90% in adults. In chronic forms of the disease, however, fish become
infected with the virus without showing any outward clinical signs or pathology of the
disease. These fish experience a prolonged course with lingering low levels of mortality,
and possibly shed the virus into the surrounding environment acting as covert carriers of
the disease. In some hosts, a chronic infection is characterized by nervous manifestations,
often associated with erratic swimming behavior (Batts & Winton, 2007; Lovy et al.,
2012; Skall et al., 2005).
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Currently, sampling of the head kidney and spleen for virus isolation using cell culture
or plaque assay, followed by confirmation by reverse-transcriptase polymerase chain
reaction (RT-PCR), is the gold standard diagnostic test for VHSV in fish (Batts &
Winton, 2007; OIE, 2009). Unfortunately, sampling of these tissues is lethal and, in
addition, the nature of this assay requires that virus be present in sufficient quantities in
these organs to produce a positive titer in a susceptible cell line, a condition that does not
always exist in fish infected with low levels of virus (Lovy et al., 2012). Because of the
wide-species host range and the active screening for virus in fish, the impact of
euthanizing a statistically sufficient number of fish can have a negative impact on a
natural population in a lake, such as the case for muskellunge (Esox masquinongy) or
northern pike (Esox lucius), or for valuable broodstocks in aquaculture. Thus, if virus can
be more accurately detected in a non-lethal manner, such as blood sampling or gill and
fin biopsy, larger numbers of fish may be screened more effectively and efficiently at a
lower cost and valuable fish stocks could be spared. To do this, however, requires a more
detailed understanding of how the pathogenicity and distribution of the VHS virus
changes in a susceptible host-fish species over time.
Using the adult yellow perch as a research model and multifaceted methods such as
quantitative PCR and fluorescence microscopy in conjunction with plaque assay, this
study examines the relative distribution of VHSV-IVb throughout the head kidney,
spleen, liver, brain, fin, gills, and blood over the course of infection in an effort to track
how the virus distribution between these tissues changes over time. This knowledge is
useful for identifying similarities and differences between VHSV and other rhabdoviruses
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in host-virus interactions and pathogenesis of disease, and will aid in the development of
a more efficient, accurate, and potentially non-lethal, identification of chronically
infected asymptomatic adult fish.

Materials & Methods
Adult yellow perch were obtained from the University of Wisconsin-Milwaukee
(UWM) School of Freshwater Science (SFS). All fish used in the study were spawned
and reared at the UWM SFS Aquaculture Research Facility according to the guidelines of
the Institutional Animal Care and Use Committee (IACUC) of the UWM as previously
described (Rosauer et al., 2011). Approximately 3-4 months prior to the challenge, all
fish used in the study were transferred to the USGS Western Fisheries Research Center
(WFRC), Seattle, WA, where they were used for the subsequent challenge experiment
under protocols approved by the IACUC of the WFRC. All virus exposure experiments
were performed in the WFRC aquatic biosafety level-3 containment laboratory.
The Great Lakes VHS virus strain IVb (MI03) was isolated from adult muskellunge,
Esox masquinongy (Mitchill) from Lake St. Clair in 2003 (Elsayed et al., 2006). The
virus was propagated using the Epithelioma papulosum cyprini (EPC) cell line (Fijan et
al., 1983b) and concentration determined by plaque assay as previously described (Batts
& Winton, 2007).
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Virus Quantification by Plaque Assay Analysis
For the first challenge experiment, 180 fish (100-150g) were equally divided between
3 treatments, each treatment conducted in 4 replicates of 15 fish/replicate. The
treatments consisted of one group (n=60 fish) exposed to VHSV by intraperitoneal (IP) injection at a titer of 1 x 104 PFU/fish, another group (n=60 fish) exposed to VHSV by
intraperitoneal (IP) -injection at a titer of 1 x 102 PFU/fish, and a third group (n=60 fish)
served as a control, and was challenged by IP injection with the same volume of Trisbuffered Eagle's minimum essential medium (MEM-10-T) used to formulate the virus
treatments. This group served to simulate the stresses of handing and injection. Water
temperature was 9°C at the start of the challenge and then raised 1.0°C daily until it
reached 12°C. All fish were fed every other day throughout the entire challenge
experiment. Of the negative control tanks and virus challenged tanks, fish from one
replicate tank in each group were monitored daily for a total of 28 days only for mortality
events to assess disease progression. From these tanks, dead fish were removed daily and
mortality data recorded. Percent survival in each tank was calculated as the cumulative
number of surviving fish divided by the total number of fish x 100. In the other three
virus treated and negative control tanks, fish were lethally sampled on days 2, 4, 7, 10,
14, 21 and 28 post-virus exposure. Each fish sampled was euthanized by an overdose (25
mg mL-1) of buffered tricaine methanesulfate (MS-222, Western Chemical Inc.), and
samples of the spleen, head kidney, gill, and fin were collected and immediately frozen
(-80°C) until plaque assay analyses could be conducted. The head kidney and spleen
samples were pooled for each individual prior to freezing.
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Plaque assay analysis on each specimen collected was conducted according to
protocol establish by the AFS Fish Health Section for the detection of VHSV (Batts and
Winton, 2007). Each sample was diluted 1:8 (weight:volume) in MEM-0 and
homogenized with a Stomacher-80 (Seward Laboratory Systems, Biomaster). Sample
homogenates were transferred into 15 mL conical tubes and spun at 4°C for 10 minutes at
1000 x g. One milliliter (mL) of supernatant from each sample was removed to quantify
infectious virus by plaque assay, and another 1 mL stored at -80°C to assess virus
genome concentrations by qRT-PCR. For plaque assay, serial 10-fold dilutions (1:40 to
1:40k) of tissue homogenate supernatants were plated in duplicate onto polyethylene
glycol (7% PEG) treated EPC cell monolayers in 24-well plates. Cell-cultures were
overlaid with methylcellulose and incubated at 15°C for 7 days before fixation with
crystal violet-formalin solution and plaque enumeration as previously described (Batts &
Winton, 1989b). Fish tissue viral titers of VHSV are reported as plaque forming units per
gram (PFU g-1).

Virus Quantification by qPCR analysis
For the second challenge experiment, only one group of triplicate tanks, containing 16
yellow perch/tank, was exposed to the VHSV by IP-injection at a titer of 1 x 104
PFU/fish as described above. Identical triplicate tanks of each fish stock serving as
negative controls were exposed to the same volume of MEM-10 used to formulate the
virus treatments at the same temperature regime. On days 5, 7, 9, 12, 14 & 21 post-virus
exposure one fish was sampled from each tank. Each fish was euthanized by an overdose
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(25 mg mL-1) of buffered tricaine methanesulfate (MS-222, Western Chemical Inc.) and
samples of the spleen, head kidney, blood, brain, gill, and fin were collected. Tissue
samples were immediately frozen (-80°C) until qPCR analyses could be completed. The
head kidney and spleen samples were pooled for each individual prior to freezing.
Blood samples of approximately 1mL were taken from each fish in a non-heperinized
syringe and kept overnight at 4°C for clotting to occur. After 12-24 hrs, samples were
spun at 13,000 rpm for 20 minutes at 4°C and serum was carefully removed. The
resulting pellet (~0.4-0.5 mL) was transferred to a new 2ml tube containing 1mL of TRI
Reagent® RT-Blood with 75µl 4-bromoanisle (MRC, Inc, cat.# RB211), vortexed for 5
minutes and frozen at -80°C until further processing could be completed. RNA extraction
into 50µl H2O was completed according to the manufactures protocol. RNA was
processed a second time to remove any interfering DNA and/or inhibiting enzymes using
the RNAqueous®-Micro Scale RNA Isolation Kit (Ambion) according to the
manufacturer’s protocol. The pooled head kidney and spleen, brain, gill, and fin samples
were collected and immediately froze at -80°C and total RNA extraction using the
RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. Complimentary
DNA was synthesized from 1 µg RNA by RT-PCR using the Applied Biosystems (ABI)
High Capacity cDNA Reverse Transcription kit according to the manufacturer’s protocol.
VHS virus primers (Forward primer 5'-ATG AGG CAG GTG TCG GAG G-3', Reverse
primer 5'-TGT AGT AGG ACT CTC CCA GCA TCC-3', Invitrogen) and MGB probe
(5'-6 FAM-TAC GCC ATC ATG ATG ATG -MGBNFQ-3', ABI) were utilized for the
qPCR assay as described in Garver et al. (2011). The RNA standard used for qPCR virus
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quantification, generated by a plasmid vector containing the N-gene of the virus, was
generously provided by Dr. Kyle Garver (Pacific Biological Station, Nanaimo, BC). A
standard curve based on a dilution series of N-transcripts ranging from 1 x108 to 1 x 101
viral gene copies was included on each qPCR plate and used to calculate virus loads
based on the resulting CT values. The VHSV qPCR assay was performed using a
LightCycler® 480 (Roche). Each qPCR assay was conducted in a 25 µL reaction volume
containing 1 µL of cDNA, 600 nM of each primer, 200 nM probe, and 12.5 µL 2x
TaqMan Universal PCR Master mix (Applied Biosystems). The thermal cycle profile
was: 2 minutes at 50ºC, 10 minutes at 95ºC, 40 cycles of 15 seconds at 95ºC, and 1
minute at 60°C (Garver et al., 2011).

Statistics
Statistical relevance was calculated using Sigma Plot® software (Systat Inc.).
Statistical analysis of gene expression relative to time of expression and tissue type was
completed using Tukey's pairwise multivariate comparisons procedure within a two-way
analysis of variance (ANOVA). Correlation results were completed using linear
regression analysis on log transformed data.

Fluorescence Microscopy
In a third challenge experiment, yellow perch were exposed to virus as described
above and on day 28 post-virus exposure, all surviving fish were euthanized and the
heads removed and immediately fixed (30% ethanol, 10% formalin, 2% glacial acetic
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acid, and 58% distilled water). Samples were shipped to and processed for microscopy at
UWM-SFS in Milwaukee, WI. The brains were carefully removed from each of the fish
heads and placed in a 20% sucrose / phosphate-buffered saline (PBS) solution overnight
at 4°C. After sucrose saturation, brain tissues were embedded in a 1:2 OTC sucrose
medium. Frozen blocks were cut into 7µm sagittal or horizontal sections onto silicone
coated slides and fixed in cold acetone for 5 min, followed by a 30 min drying period at 20°C. Tissues were then rehydrated with a series of 5 min incubations with PBS followed
by a 30 min block with 10% normal goat serum (NGS) in PBS with 0.1% Tween.
Sections were blocked a second time with a commercially available Image-iT® FX
Signal Enhancer Reagent (Molecular Probes, cat# R37107) to further reduce non-specific
staining or background fluorescence. Tissues were washed two more times using 10%
NGS/PBS with 0.1% Tween before incubation with anti-VHSV monoclonal antibody
(Aquatic Diagnostics Ltd., Scotland) diluted 1:10 in PBS in a humid chamber for 1 hour
at room temperature. Tissue sections were washed an addition 3 times, 30 min each,
using 10% NGS/PBS before incubation with Alexa Fluor 594 (AF594) goat anti-mouse
IgG fluorescent conjugate (Molecular Probes, cat# A31624) diluted 1:1000 in 10%
NGS/PBS for 15 min at 4°C. This was followed by 5 consecutive 5-10 min washes with
10% NGS/PBS at room temperature and mounted with Vectashield® with DAPI for
nuclear staining (Vector Laboratories, cat# H1200).
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Results
In the tanks of fish reserved only for mortality monitoring, fish exposed to VHSV at a
dose of 1 x 102 PFU/fish had 67% cumulative survival (10/15), while fish exposed to
VHSV at a dose of 1 x 104 PFU/fish had 60% cumulative survival (9/15) (Figure 4-1). No
mortalities were observed in any of the negative control tanks. Statistical analysis verified
that no significant difference in cumulative survival existed between fish exposed to the
two VHSV titers (P = 0.532).
Despite a relatively high mortality in each of the tanks (33% low dose and 40% high
dose), external clinical signs of the disease remained very mild and were often not visible
in fish that had succumbed to the disease in either treatment group. When external
clinical signs were visible, they most frequently consisted of mild exophthalmia, or
swelling of the eye, as well as slight hemorrhage on the fins and the base of the anus. Fish
with external signs did not always die from the disease, and most appeared to recover
from clinical signs of VHS by day 21 post-VHSV injection. Hemorrhages around the
brain, eye sockets, and liver, as well as moderate ascites in the abdominal cavity,
however, were the most often apparent internal signs of the sampled fish. Since many of
the fish that had died during the 28-day challenge did not exhibit external signs of the
disease, plaque assay analysis was conducted on the pooled head kidney and spleen on all
individual fish to confirm the presence of VHSV. Because mild exophthalmia was the
most common clinical sign exhibited during the challenge, the brain was also extracted
and included in the analysis. This analysis of the fish that had succumbed to the disease
confirmed relatively high titers of VHSV in the pooled head kidney/spleen and brain. The
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geometric mean viral titer in the brain was 5.57 x 108 PFU g-1, while the geometric mean
viral titer in the pooled head kidney/spleen was 6.72 x 108 PFU g-1. No significant
difference in viral titer between the brain and pooled kidney/ spleen was detected (n=8
fish, data not shown).
VHSV titer was analyzed by plaque assay in the tissues, head kidney/spleen, gill, and
fin over the first 28 days post-VHSV injection. In fish exposed to the virus at a dose of 1
x 102 PFU/fish, three fish were sampled (1 fish/tank) on days 2, 4, 7, 10, 14, 21 and 28
days post-VHSV exposure (Figure 4-2, Table 4-1). On day 2 post-VHSV exposure, virus
was only detected in the fin in 1/3 fish analyzed. While viral detection in the pooled head
kidney and spleen became evident on day 4. On day 10, VHSV was only detected in 2/3
fish, but in the gill and fin it was detected in all 3/3 fish sampled. By day 28 post-VHSV
exposure, VHSV was detected in the pooled head kidney and spleen in 1/3 fish (62% of
fish overall), the gill in 2/3 fish (67% of fish overall), and the fin in 0/3 fish (57% of fish
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Figure 4-1. Adult yellow perch were exposed to VHSV-IVb at two viral
titers, 1 x 102 and 1 x 104 PFU/fish, and survival monitored daily in each
group over 28 days. Overall, cumulative percent survival (67% vs 60%) was
not significantly different between the two groups.
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Figure 4-2. The geometric mean of VHS viral titer (PFU g-1) determined by plaque
assay in all three tissues (pooled head kidney/spleen (Hk/Sp), fin and gill) in fish
exposed to a viral titer of 1 x102 PFU/fish over time.

Low Titer Day

2

4

7

10

14

21

28

Kd/sp
Gill
Fin

0/3
0/3
1/3

2/3
1/3
0/3

3/3
3/3
3/3

2/3
3/3
3/3

3/3
3/3
3/3

2/3
2/3
2/3

1/3
2/3
0/3

Total
13/21
14/21
12/21

% Pos.
62%
67%
57%

Table 4-1. VHSV prevalence determined by PA in fish exposed to a viral titer of
1 x102 PFU/fish.
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overall) (Table 4-1). When viral titer in time point-sampled fish was analyzed, no
significant difference was found between viral titer in the three tissues. All mock-injected
fish sampled during the were negative for virus, and fish that had died in the VHSVexposed sampling tanks showed significant levels of virus in the pooled head kidney and
brain as described above.
In fish exposed to the higher viral titer of 1 x 104 PFU/fish, three fish were sampled (1
fish/tank) on days 2, 4, 7, 10, 14, 21 and 28 days post-VHSV exposure (Figure 4-3,
Table 4-2). Unlike fish in the low titer challenge, a relatively high viral titer was
immediately detected in only the pooled head kidney/spleen on day 2 post-VHSV
exposure (Figure 4-3, Table 4-2). However, as with the fin in the lower titer challenge,
this was only detected in 1/3 fish tested, although the gill and fin from the same fish
tested negative. While virus was detected in the pooled head kidney/spleen in all 3/3 fish
sampled on days 4 and 21 post-VHSV exposure, it was only detected in 2/3 fish on days
7, 10 and 14, despite a positive detection of VHSV in the gill and fin in all 3/3 fish on
each sampling day. By day 28 post-VHSV exposure, VHSV was not detected in the
pooled head kidney and spleen in any of the fish tested (62% of fish overall), the gill in
1/3 fish (71% of fish overall), and the fin in 0/3 fish (62% of fish overall) (Table 4-2.).
When viral titer in positive fish was analyzed, no significant difference was found
between the three tissues, however, overall viral titer was statistically significantly higher
in each tissue in fish exposed to the high titer (1 x 104 PFU/fish) on days 10 and 21 postVHSV exposure relative to fish exposed to the lower titer (1 x 102 PFU/fish) (P<0.05).
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Figure 4-3. The geometric mean of VHS viral titer (PFU g-1) determined by plaque
assay (PA) in all three tissues (pooled head kidney/spleen (Hk/Sp), fin and gill) in fish
exposed to a viral titer of 1 x104 PFU/fish over time. Astericks indicate where viral titer
was statistically significantly higher in each tissue in fish exposed to the high titer (1 x
104 PFU/fish) on days 10 and 21 post-VHSV exposure relative to fish exposed to the
lower titer (1 x 102 PFU/fish) (P<0.05).

High Titer Day

2

4

7

10

14

21

28

Kd/sp
Gill
Fin

1/3
0/3
0/3

3/3
2/3
1/3

2/3
3/3
3/3

2/3
3/3
3/3

2/3
3/3
3/3

3/3
3/3
3/3

0/3
1/3
0/3

Total
13/21
15/21
13/21

Table 4-2. VHSV prevalence determined by plaque assay (PA) in fish exposed
to a viral titer of 1 x104 PFU/fish.

% Pos.
62%
71%
62%
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In the second challenge experiment, fish were exposed to a viral titer of 1 x 104
PFU/fish as in the previous challenge, however, VHSV load was analyzed by qPCR in
the pooled head kidney/spleen, blood, brain gill, and fin in 3 fish sampled (1 from each
tank) at each time point, days 5, 7, 9, 12, 14 and 21 days post-VHSV exposure (Figure 44, Table 4-3). While virus was detected in the pooled head kidney and blood on every
sampling day (88% and 94% of all samples respectively), virus was not detected in the
fin until day 12, 14 & 21 (31% of all fish sampled), and in the gill on days 5, 12, 14, and
21 (45% of all fish sampled). Only on day 9 was VHSV not detected in the pooled head
kidney and spleen, but positive in the blood of one of the fish sampled (Table 4-3).
Alternatively, in no case was there a positive detection of VHSV in the pooled head
kidney and spleen, but not in the blood. VHSV detection in the brain also began on day 9
(44% of all fish sampled), however peaked to the highest viral load detected in all tissues
on day 21. Viral titer in the pooled head kidney/spleen, blood, and brain was statistically
significant relative to the fin and gill on day 14 post-VHSV exposure (P<0.05). Linear
regression analysis confirmed a significant correlation between viral load detected in the
pooled head kidney/spleen and blood over the course of the challenge experiment (F (1, 14)
=42.783, R2=0.75) (Figure 4-5).
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Figure 4-4. The geometric mean of VHS viral load (copy # µg-1 RNA) determined by
qPCR assay in the pooled head kidney/spleen (Hk/Sp), fin, gill, blood and brain in fish
exposed to a viral titer of 1 x104 PFU/fish over time.
qPCR
High titer - Day

5

7

9

12

14

21

Hk/Sp
Blood
Brain
Gill
Fin

3/3
3/3
0/3
1/2
0/2

2/3
2/3
0/3
0/2
0/2

2/3
3/3
1/3
0/2
0/3

3/3
3/3
2/3
1/2
1/3

2/2
2/2
2/2
1/1
1/2

2/2
2/2
2/2
2/2
2/2

Total
14/16
15/16
7/16
5/11
4/14

Table 4-3. VHSV prevalence determined by qPCR in fish exposed to a viral titer
of 1 x104 PFU/fish.

% Pos.
88%
94%
44%
45%
29%
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Figure 4-5. Linear regression analysis indicating a significant correlation
between VHS viral load (copy # µg-1 RNA) detected in the blood versus the
pooled head kidney and spleen (Hk/Sp) by qPCR.
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Fluorescence microscopy imaging using a fluorescently conjugated monoclonal antiVHSV antibody was conducted on sectioned brain tissues of fish 28 days-post-VHSV
exposure. Despite being asymptomatic for VHS infection, the presence of VHSV positive
erythrocytes was identified within the optic tectum of the brain (Figure 4-6 A & B). VHS
virus was also identified with leukocytes in the same region (Figure 4-7). Additional
tissue analysis also indicated heavy staining for VHSV positive neural cell bodies of the
optic tectum (Figure 4-8 A), and axonal tracts within the telencephalon (Figure 4-9 A).
The presence of VHSV in peripheral nerve axons was also visible in a longitudinal
section of a cranial nerve (Figure 4-10 A), a cross-section of an axonal tract running
through the thalamus (Figure 4-11 A), and hindbrain (Figure 4-11 B). Nuclear staining of
the tissue revealed that virus remained in the cytoplasm of the neurons and was not
associated with the nucleus in any stage of infection (Figure 4-8 B, Figure 4-9 B, Figure
4-10 B).

Discussion
This study was unique in that it examined the viral distribution and pathology in a
population of largely asymptomatic adult yellow perch infected with the Great Lakes
strain VHSV-IVb. This is in contrast to other studies that have only examined the
susceptibility of juvenile fish to the VHSV-IVb, where young fish exhibited severe to
moderate external signs of the disease including hemorrhage throughout the body, fin
bases and exophthalmia at similar viral titer exposures, and viral distribution not yet
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explored (Kim & Faisal, 2010b; Olson et al., 2013). Alternatively, in the current study,
clinical manifestations of VHS as external signs, including mild hemorrhage of the fins

A.

B.

Figure 4-6. VHS virus positive erythrocytes within the brain tissue of
VHSV-exposed fish. (A) Light microscopy DIC image of erythrocytes
identified within the optic tectum of an adult yellow perch brain. (B)
Fluorescent microscopy image using a monoclonal antibody to identify
VHSV (red).
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Figure 4-7. Fluorescence microscopy image indicating a VHS virus (white)
positive leukocyte in a brain section of a VHSV-exposed adult yellow perch.
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A.

200µm

B.

200µm

Figure 4-8. Fluorescence microscopy indicating VHS virus (A)
(white) within neural cell bodies of the optic tectum. (B) Staining of
the cellular nuclei within the tissues (blue) revealed that VHS virus
(pink) remained in the cytoplasm of the neurons.
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A.

200µm

B.

200µm

Figure 4-9. Fluorescence microscopy image in a brain section of a
VHSV-exposed adult yellow perch indicating VHS virus (A) (white)
within the axonal tracts of the telencephalon, and (B), VHS virus
(pink) does not translocate with the cellular nuclei (blue).
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Figure 4-10. Fluorescence microscopy image in a brain section of a
VHSV-exposed adult yellow perch indicating VHS virus (A.)
(white) within a longitudinal section of a cranial nerve, and (B),
VHS virus (pink) does not translocate with the cellular nuclei (blue).
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Figure 4-11. Fluorescence microscopy image in a brain section of a
VHSV-exposed adult yellow perch indicating VHS virus (white) within
(A) a cross-section of an axonal tract running through the thalamus, and
(B) hindbrain.
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and exophthalmia, were rarely observed in fish that had died during the adult yellow
perch virus challenge; only internal signs were observed. In addition, particularly in fish
injected with the lower titer of VHSV, the fish died very gradually instead of as a group.
The occasional death of only a few fish at a time, combined with the lack of external
signs, suggests that die-offs resulting from the manifestation VHSV in adult fish may
easily go unnoticed in a natural lake environment. Fish that had demonstrated clinical
signs during the early stages of infection also appeared to recover as survivors of the 28day challenge.
In the present study, the identification of virus in the gill by plaque assay in fish which
tested negative for infection in the head kidney/spleen suggests that this tissue may
harbor virus in cases of low level infection. The detection of live, replication capable
VHSV in the gill may be useful for the monitoring for VHSV in aquatic organisms since
VHSV in the gill may also be an indicator of viral shedding in a chronically infected
carrier fish. Similar studies with VHSV-Ia have identified the gill epithelium as a target
for viral replication (Yamamoto et al., 1992), and a recent study confirmed that a rainbow
trout gill epithelial cell line (RTgill-W1), but not spleen macrophage cell line (RTS11),
will support replication of VHSV-IVb (Pham et al., 2013). This correlates with our
findings of VHS virus in the gill, but not the pooled head/spleen samples, suggesting that
the macrophage rich organs of the head kidney and spleen maybe capable of clearing the
virus from these tissues, while the gill epithelium may not. Thus, the relatively high
prevalence of VHS virus detected by plaque assay suggest that the gill in particular may
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serve as a useful tool for non-lethal detection measures, particularly in fish that may not
have actively replicating virus in the head kidney or spleen.
When VHS virus was examined by qPCR, virus was consistently detected in the blood
in nearly all (94%) of the fish that were sampled with a significant correlation to viral
load detected in the pooled head kidney/spleen (F (1, 14) = 42.783, R2=0.75). In one of the
fish analyzed, a positive detection of virus in the blood correlated with a negative
detection in the pooled head kidney and spleen, suggesting that analysis of the blood may
be even more representative of viral infection. Excluding this fish from the analysis (as a
possible outlier), however, increases the correlation between the pooled head kidney and
spleen even greater (F (1, 14) = 91.152, R2=0.87). The finding of a significant correlation
between viral load detected in the blood and the pooled head kidney/spleen over the
course of the 21-day challenge suggests that blood could be used as an accurate nonlethal sampling tool in place of the lethal analysis of the head kidney and spleen.
As in this study, VHSV-IVb antigen-associated leukocytes have been detected in several
other Great Lakes fish species (Al-Hussinee et al., 2010; Al-Hussinee et al., 2011).
Blood has also been used for the detection of VHSV-Ia relative to viral load in head
kidney and spleen in infected rainbow trout (Oncorhynchus mykiss) (Cuesta & Tafalla,
2009), however, with less robust results, possibly due to inhibitory enzymes present in
the extracted RNA due to the presence of serum. Alternatively, VHSV-IVb may have
evolved a slightly higher affinity for cells in the blood, particularly erythrocytes, resulting
in a more pathogenic virus capable of infecting a wide array of new host-species. In
addition, as research in anti-VHSV antibody production and detection continues to
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improve (McLauchlan et al., 2003; Millard & Faisal, 2012; Pereiro et al., 2012; Purcell et
al., 2012), the potential use of blood and serum as a non-lethal means for both the
detection of VHSV and anti-VHSV antibody holds more promise than ever before.
The discovery of VHSV antigen associated erythrocytes in the brain tissue of infected
fish also provides valuable insight into how the virus is potentially spread throughout
various tissues within the fish. Unlike mammalian erythrocytes, nucleated red blood cells
of fish have been shown to be fully functional immune cells capable of eliciting pathogen
associated molecular pattern-specific responses (Montero et al., 2011). Because fish lack
a lymphoid system, and teleost erythrocytes maintain a nuclei and functional cellular
machinery, it would be highly beneficial for the virus to have adapted the use of these
cells for quick transport and dispersal to tissues throughout the body. The infection of red
blood cells in fish is not novel in that is has long been the characteristic signature of the
iridovirus, erythocytic necrosis virus (ENV) (Glenn et al., 2012; Smail, 1982). Unlike
ENV, however, which is easily visualized by the identification of intracytoplasmic
inclusion bodies in infected cells, VHSV, like all rhabdoviruses, sheds its glycoprotein
upon cellular entry and replicates in the cytoplasm, thus the viral capsid cannot be easily
visualized. While in this study, fluorescence microscopy confirmed the presence of VHS
virus in red blood cells using an N-gene specific monoclonal anti-VHSV antibody,
studies to determine whether or not the virus is still infectious, or can replicate within
these cells remain.
Viral detection by plaque assay, qPCR, as well as fluorescence microscopy, also
confirmed VHS virus accumulation in the brain, particularly in the later stages of

104

infection in association with hemorrhage and the likely introduction through VHSV
infected blood and virally infected neural axons. This finding is consistent with other
reports of VHSV in the brain tissues of chronically infected juvenile rainbow trout
(Oncorhynchus mykiss) (Brudeseth et al., 2002) and Pacific herring (Clupea pallasii)
(Lovy et al., 2012), providing further evidence that the same is true of VHSV-IVb in
adult yellow perch. Targeting of the brain is a characteristic similar to another
rhabdovirus capable of infecting multiple host-species, rabies. This small, negative strand
RNA virus is exclusively known as a prototypical neurotrophic virus, but the mechanisms
of neural transport via peripheral axons to the brain may be similar. Like rabies, our
results suggests that the VHS virus spreads in the blood, and it can enter CNS neurons at
a peripheral sites and travel through the spinal cord to the brain of the infected host
(Kelly & Strick, 2000). Unlike the rabies virus, however, it is unknown if the VHS virus
is capable of replicating within the neuron and inducing apoptosis, or if the virus can
sustain in the cranial neurons long-term.
In summary, the results of this study suggest a low level of VHSV-IVb infection in
adult yellow perch may easily go undetected since no clinical signs were apparent in most
of the fish in this study. When blood and brain tissues were included in the second
challenge, analysis by qPCR demonstrated that blood, in combination with plaque assay
of the gill, might provide a viable and accurate way of screening for VHSV in larger,
more valuable fish in a non-lethal manner. The finding of significant virus in the brain,
possibly through the transport of VHSV associated erythrocytes and neural axons,
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however, also suggests that this tissue may be the target organ and source of chronic
infection in long-term asymptomatic carriers of infection in adult yellow perch.
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Chapter 5

Final Discussion

Overall, for a successful viral infection and the onset of disease to occur, proper
conditions must be met within three primary areas, the external environment, the species
population, and the individual fish immune system (Figure 5-1). Previous studies have
verified that the VHSV-IVb virus is only capable of replicating in water temperatures
below 18°C, with optimal replication occurring between 9-12°C (Goodwin & Merry,
2011). External stressors in a lake such as low oxygen as in hypoxia or anoxia, combined
with rapid temperature changes characteristic to large lake environments in the winter
and spring, can also compromise the fish immune system, increasing chances of
susceptibility. Farm raised fish held at similar temperatures may also become immune
compromised due to stresses such as shipping and crowding during transport, making
them more susceptible to disease outbreak as well. Another significant factor that will
determine disease susceptibility within a population is the species of fish, since large
differences appear to exist between fish species in susceptibility to VHSV-IVb.
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Environment

 Cold Water (4-15°C)

Species
Population

 External Stress
-Hypoxia/Anoxia
- Rapid Temp. Change
- Shipping/ Crowding

 Species Susceptibility
 Internal Stress
-Spawning

Individual
Immune
System

 Susceptible Host
Genetics
 Three Components
-Barrier
- Innate
- Acquired

Figure 5-1. Conditions must be met in three generalized components for successful
VHSV infection and the onset of disease to occur. A common variable influenced and
shared in all three components to VHS susceptibility is stress.
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Populations within a species, however, will react differently to VHSV exposure due to
genetic differences and stresses brought on by external changes in the environment,
and/or internal stress such as spawning. Within an individual fish, activation of a proper
immune response will ultimately dictate whether or not the disease will progress. The
results presented here indicate that a large component of a healthy immune response will
depend on genetic factors and stress, both internal and external. Thus, provided general
conditions for the virus to replicate are met (i.e., water temperature and species
susceptibility), stress and genetics are ultimately the two factors which will influence
disease susceptibility and outbreak the most.
The first chapter of this study identified major differences in susceptibility to the Great
Lakes VHSV-IVb strain within a single species of yellow perch in three populations
derived from different genetic and geographic origins. With all environmental conditions
held equal, the most predominant differences between individuals, and thus the factors
that would determine the outcome of VHSV infection and disease, were host genetics.
Because genetic diversity was not significantly different between populations, a factor
often attributed to differences in susceptibility to disease, it may be hypothesized that the
existence of certain disease resistance genetic traits shaped by the host population's
previous environment are responsible. As mentioned earlier, studies have confirmed that
fish from the Great Lakes region most likely have never been exposed to VHS virus or
any similar rhabdovirus before the identification of VHSV-IVb (Elsayed et al., 2006;
Kim & Faisal, 2010a; Kim & Faisal, 2011; Olson et al., 2013; Pierce & Stepien, 2012).
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Therefore, previous generations have not been influenced by the same natural selection
pressures as the fish from the East coast. Alternatively, the perch stocks from the
Choptank River and Perquimans River, both river estuary environments on the east coast
of the U.S., may have encountered marine strains of VHSV (Gagne et al., 2007) and
other viruses. Thus, natural selection pressures would have eliminated fish that did not
survive viral exposure, allowing for the development of more virus resistant offspring to
occur. In addition, however, the individual stress level also appeared to be highest in the
susceptible population originating from Lake Winnebago, WI. As mentioned earlier, it
was reported that Lake Winnebago fish seemed more easily stressed by human
interactions (e.g., tank cleaning, adjusting feeders, and peering into or walking by the
tank), than Choptank or Perquimans River fish. In all vertebrates, as well as fish, elevated
levels of stress can result in elevated cortisol and a chronic overactive pro-inflammatory
state, which can contribute to an increase susceptibility to disease (Miller et al., 2008).
The second chapter of this study focuses exclusively on the early innate immune
pathways triggered relative to viral load by VHSV-IVb infection in a highly susceptible
population of fish during the very early stages of infection. The administration of VHSVIVb by IP-injection into juvenile yellow perch resulted in 84% mortality, indicating their
high susceptibility to this disease. However, it was also found that yellow perch mount a
strong innate immune response to VHSV-IVb as demonstrated by significant increase in
expression by pro-inflammatory genes IL-1β and SAA. In addition, a down-regulation of
an anti-viral immune response indicated by a decrease in Mx gene expression in the
hematopoietic tissues, head kidney and spleen, may represent a strategy utilized by the
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virus to increase replication. It is therefore also possible that the fish from Lake
Winnebago, WI may have experienced significantly high down-regulation of the Mx
gene, resulting in an insufficient antiviral innate immune response and a high proinflammatory response, possibly as a result of increased chronic stress, resulting in an
increase in overall susceptibility to the disease relative to the other stocks.
In the final chapter of the study, the viral distribution was tracked over time in
infected fish. Interestingly, in the juvenile yellow perch infected with a similar dose of
VHSV in the first two chapters of the study, the clinical signs observed in the infected
perch were similar to signs of VHS virus in other species, including septicaemic
hemorrhages throughout the body and at the base of the fins. The transparency of dead
juvenile perch allowed us to observe severe internal hemorrhages around the brain,
suggesting that infected fish may suffer permanent damage to the central nervous system
and that the brain may be a potential viral reservoir in surviving fish. In the adult fish,
however, rarely were external clinical signs of the disease observed. Mild exophthalmia,
or swelling of the eyes was the most common sign exhibited, however, it also seemed to
disappear in the fish over time, again suggesting internal hemorrhage around the brain of
the fish (Figure 5-2). The final study confirmed this hypothesis with the discovery of high
virus loads in the brain of VHSV infected fish, particularly in the later stages of infection.
In addition, this study demonstrated that analysis for VHSV in the blood by qPCR, in
combination with plaque assay of the gill, may provide a viable and accurate way of
screening for VHSV in larger, more valuable fish in a non-lethal manner.
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Figure 5-2. Exophthalmia, or swelling of the eye was the most common
clinical sign associated with VHSV infection in adult yellow perch.

From the culmination of this and previous studies, we can begin to understand how
VHSV-IVb infects yellow perch in different stages of infection. In the waterborne
transmission of virus, recent studies suggest that the main portal of viral entry and
replication may be at the base of the fins (Harmache et al., 2006; Montero et al., 2011),
as well as oral transmission of VHSV through the predation of infected fish (Schonherz et
al., 2012). Once a fish is infected with the VHSV, the suppression of the interferon
response, combined with activation of a pro-inflammatory response, may result in
successful replication of virus in the target tissues, head kidney and spleen. The spleen
and head kidney of the fish represent hematopoietic tissues that are rich in leukocytes and
erythrocytes from the continual circulation of blood. Therefore, the detection of VHSV in
the blood and VHSV-associated erythrocytes and leukocytes, suggest a mechanism for
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the virus to be quickly transported and dispersed to all tissues of the fish in conjunction
with internal hemorrhaging. Since VHSV-IVb is capable of replication primarily within
epithelial cells (Batts & Winton, 2007), translocation to the skin and gills (shown in
chapter 4) can rapidly occur and represent key tissues where virus shedding may take
place. Targeting of the brain by VHSV-IVb was also demonstrated in this study, possibly
through the transport of VHSV-associated erythrocytes and retrograde travel through
peripheral axons. This and other studies also suggest (Brudeseth et al., 2002; Lovy et al.,
2012) that the brain may be an additional target organ and source of chronic infection in
long-term asymptomatic carriers of infection in adult yellow perch. Once the virus
establishes itself, this opportunistic pathogen may remain hidden or latent in apparently
healthy populations of fish until a significant stressor again triggers an active infection,
repeating the cycle of infection and disease once more.
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Mercury as a Global Pollutant in Madison, WI. (Aug 6-11, 2006).

Quality Control Chemist
Sigma-Aldrich Corporation Fine Chemicals Inorganics Division, Milwaukee, WI

6/00- 6/05

 Designed and implemented methods of analysis involving new technologies resulting in
greater speed and accuracy of testing quality and quantity of inorganic compounds.
 Regularly trained new employees as well as provided troubleshooting support to fellow
coworkers regarding inorganic analysis instrumentation and methods.
 Actively involved in the validation/testing of various chemical reagents to meet specific
pharmaceutical and/or research grade quality guidelines.
 Continually involved in compliance issues regarding documentation and process control
to meet ISO 9000 regulations.
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